1<!DOCTYPE html> 2<html> 3 <head> 4 <!-- Basic --> 5 <meta charset="utf-8"> 6 <meta name="viewport" content="width=device-width, initial-scale=1"> 7 8 <title>EMERG European ME Research Group - the Network of European ME Researchers </title> 9 10 <meta name="keywords" content="European ME Research Group" /> 11 <meta name="description" content="European ME Research Group"> 12 <meta name="author" content="EMERG"> 13 14 <meta name="CATEGORY" content="EMERG"> 15 <meta name="keywords" content="EMERG, European ME Research Group" /> 16 <meta name="description" content="EMERG"> 17 <META name="Copyright" content="Copyright 2023 EMERG Design "> 18 19 20 21 <!-- ====================================== --> 22<!---Main Header Links for EMERG -------------------------------------------------------------------------------------------------------------------------------------------------> 23<!-- INDEX HEADER links block Addcurrent and previous versions below 24 this allows one file to be changed when version needs updating --> 25<!--include virtual="/01 Base-Common-Html-EMERG/Base-header-main-emerg-Common-linksV01.html" --> 26 27 <!-- Basic --> 28 <meta charset="utf-8"> 29 <meta name="viewport" content="width=device-width, initial-scale=1"> 30 31 32 <!-- Favicon --> 33 <link rel="shortcut icon" href="img/favicon.ico" type="image/x-icon" /> 34 <link rel="apple-touch-icon" href="img/apple-touch-icon.png"> 35 36 <!-- Mobile Metas --> 37 <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1.0, shrink-to-fit=no"> 38 39 <!-- Web Fonts --> 40 <link id="googleFonts" href="https://fonts.googleapis.com/css?family=family=Lora:400,400i,700,700i|Poppins:300,400,500,600,700,800,900&display=swap" rel="stylesheet" type="text/css"> 41 42 <!-- Vendor CSS --> 43 <link rel="stylesheet" href="vendor/bootstrap/css/bootstrap.min.css"> 44 <link rel="stylesheet" href="vendor/fontawesome-free/css/all.min.css"> 45 <link rel="stylesheet" href="vendor/animate/animate.compat.css"> 46 <link rel="stylesheet" href="vendor/simple-line-icons/css/simple-line-icons.min.css"> 47 <link rel="stylesheet" href="vendor/owl.carousel/assets/owl.carousel.min.css"> 48 <link rel="stylesheet" href="vendor/owl.carousel/assets/owl.theme.default.min.css"> 49 <link rel="stylesheet" href="vendor/magnific-popup/magnific-popup.min.css"> 50 51 <!-- Theme CSS --> 52 <link rel="stylesheet" href="css/theme.css"> 53 <link rel="stylesheet" href="css/theme-elements.css"> 54 <link rel="stylesheet" href="css/theme-blog.css"> 55 <link rel="stylesheet" href="css/theme-shop.css"> 56 57 <!-- Demo CSS --> 58 <link rel="stylesheet" href="css/demos/demo-it-services.css"> 59 60 <!-- Skin CSS --> 61 <link id="skinCSS" rel="stylesheet" href="css/skins/skin-it-services.css"> 62 63 <!-- Demo CSS --> 64 <link rel="stylesheet" href="css/demos/demo-finance.css"> 65 66 <!-- Skin CSS --> 67 <link id="skinCSS" rel="stylesheet" href="css/skins/skin-finance.css"> 68 69 <!-- Theme Custom CSS --> 70 <link rel="stylesheet" href="css/custom-em.css"> 71 72 <!-- Head Libs --> 73
73<script src="vendor/modernizr/modernizr.min.js"></script>
73 74 75 76 <!--Cookie Consent --> 77 <link rel="stylesheet" type="text/css" href="https://cdn.jsdelivr.net/npm/cookieconsent@3/build/cookieconsent.min.css" /> 78 79 80 81 82 83 84 85 86 87 </head> 88 <body> 89 90 <div class="body"> 91 92 93<!----------------------------------------------------------------------------------------------------------------------------------------------------> 94<!-- INDEX HEADER block --> 95<!---Main Header Menu for EMERG -------------------------------------------------------------------------------------------------------------------------------------------------> 96<!-- INDEX HEADER block Add current and previous versions below 97 this allows one file to be changed when version needs updating --> 98<!--include virtual="/01 Base-Common-Html-EMERG/Base-Header-Emerg-CommonV04.html" --> 99<!--include virtual="/01 Base-Common-Html-EMERG/Base-Header-Emerg-CommonV05.html" --> 100 101<!--include virtual="/01 Base-Common-Html-EMERG/Base-header-main-emerg-Common-Header-2024-04.html" --> 102 103<!-- include virtual="/00 Base-Common-Html/Base-header-main-emerg-Common-Header-2024-06.html" --> 104 105 <header id="header" class="header-effect-shrink" data-plugin-options="{'stickyEnabled': true, 'stickyEffect': 'shrink', 'stickyEnableOnBoxed': true, 'stickyEnableOnMobile': false, 'stickyChangeLogo': true, 'stickyStartAt': 120, 'stickyHeaderContainerHeight': 90}"> 106 <div class="header-body border-top-0 box-shadow-none"> 107 <div class="header-container container "> 108 <div class="header-row"> 109 <div class="header-column"> 110 <div class="header-row"> 111 <div class="header-logo"> 112 <a href="em-index.shtml"> 113 <img alt="EMERG" width="212" height="92" src="../img/logos/emerglogo24-01.png"> 114 </a> 115 </div> 116 </div> 117 </div> 118 <div class="header-column justify-content-end"> 119 <div class="header-row"> 120 <div class="header-nav header-nav-line header-nav-bottom-line header-nav-bottom-line-effect-1 order-2 order-lg-1"> 121 <div class="header-nav-main header-nav-main-square header-nav-main-dropdown-no-borders header-nav-main-effect-2 header-nav-main-sub-effect-1"> 122 123<nav class="collapse header-mobile-border-top"> 124 125 <ul class="nav nav-pills flex-column flex-lg-row" id="mainNav"> 126 127 <li class="dropdown dropdown-mega order-1"> 128 129 </li> 130 <li class="dropdown dropdown-mega order-2"> 131 <a class="dropdown-item dropdown-toggle" href="../em-index.shtml"> 132 Home 133 </a> 134 </li> 135 136 137 <!-- 138 <li class="dropdown dropdown-mega order-3"> 139 <a class="dropdown-item dropdown-toggle" href="../em-research-news.shtml"> 140 Research 141 </a> 142 </li> 143 --> 144 145 146 <li class="dropdown order-3"> 147 <a class="dropdown-item dropdown-toggle" >Research</a> 148 <ul class="dropdown-menu"> 149 <li><a class="dropdown-item" href="../em-index.shtml#research">Current research</a></li> 150 <li><a class="dropdown-item" href="../em-index.shtml#team">EMERG team</a></li> 151 152 153 154 </ul> 155 </li> 156 157 158 159<!-- Information ------------------------------------> 160 161 <li class="dropdown order-4"> 162 <a class="dropdown-item dropdown-full-color dropdown-primary" > 163 Information 164 </a> 165 <ul class="dropdown-menu "> 166 <li><a class="dropdown-item" href="../whatisme.shtml">What is ME</a></li> 167 <li><a class="dropdown-item" href="../meinEurope.shtml">ME in Europe</a></li> 168 <li><a class="dropdown-item" href="../ec-home.shtml">European ME Clinicians</a></li> 169 <li><a class="dropdown-item" href="https://youngemerg.com">Young EMERG</a></li> 170 <!-- <li><a class="dropdown-item" href="diagnosis.shtml">Diagnosis</a></li> --> 171 <!-- <li><a class="dropdown-item" href="guidelines.shtml">Guidelines</a></li> --> 172 <!-- <li><a class="dropdown-item" href="treatmentnews.shtml">Treatment</a></li> --> 173 174 <li><a class="dropdown-item" href="../faqs.shtml">FAQs</a></li> 175 </ul> 176 177 </li> 178 179 180 <li class="dropdown order-5"> 181 <a class="dropdown-item dropdown-toggle" href="../em-aboutus.shtml">About</a> 182 <ul class="dropdown-menu"> 183 <li><a class="dropdown-item" href="../em-index.shtml#contact"> Contact </a></li> 184 <li><a class="dropdown-item" href="../em-index.shtml#about">About EMERG</a></li> 185 <li><a class="dropdown-item" href="../em-index.shtml#team">EMERG team</a></li> 186 187 188 </ul> 189 </li> 190 191<!-- News / Events ------------------------------------> 192 <li class="dropdown order-6"> 193 <a class="dropdown-item dropdown-toggle" href="../news.shtml"> 194 News 195 </a> 196 <ul class="dropdown-menu"> 197 <li><a class="dropdown-item" href="../news.shtml">News</a></li> 198 <li><a class="dropdown-item" href="../em-events.shtml">Events</a></li> 199 200 </ul> 201 </li> 202 203 204 205 </ul> 206</nav> 207 208 209 210 </div> 211 <button class="btn header-btn-collapse-nav" data-bs-toggle="collapse" data-bs-target=".header-nav-main nav"> 212 <i class="fas fa-bars"></i> 213 </button> 214 </div> 215 </div> 216 </div> 217 <div class="header-nav-feature header-nav-features-search d-inline-flex"> 218 <div class="header-nav-features-dropdown header-nav-features-dropdown-reverse header-nav-features-dropdown-mobile-fixed" id="headerTopSearchDropdown"> 219 <form role="search" action="page-search-results.shtml" method="get"> 220 <div class="simple-search input-group"> 221 <input class="form-control text-1" id="headerSearch" name="q" type="search" value="" placeholder="Search...">
222 <span class="input-group-append"> 223 <button class="btn" type="submit"> 224 <i class="fa fa-search header-nav-top-icon"></i> 225 </button> 226 </span> 227 </div> 228 </form> 229 </div> 230 </div> 231 <ul class="header-social-icons social-icons"> 232 <li class="social-icons-twitter"><a href="https://twitter.com/euromeresearch" target="_blank" title="Twitter"><i class="fab fa-twitter"></i></a></li> 233 </ul> 234 </div> 235 </div> 236 </div> 237 </header> 238 239 240 241 242 243 244 <div role="main" class="main"> 245<a id="about"></a> 246 <img src="img/slides/emergbanner.png" width="1702" height="642" class="img-fluid" alt=""> 247 248 249 250 <div class="bg-grey-100 my-5 px-3 px-xl-0 border-radius-2 p-relative overflow-hidden"> 251 <div class="container "> 252 <div class="row "> 253 <div class="col"> 254 255 <!-- DESCRIPTION --------------------------------------------------------------------------------------------------------------------> 256 257 258 <div class="col"> 259 <div class="row mb-2 pb-3"> 260 261 262 <h4 class=" text-lg-8 font-weight-semibold line-height-1 "> 263 264 European Strategy for Research into Myalgic Encephalomyelitis 265 </h4> 266 267 <div class="col-md-8"> 268 269 270 271 272 <!-- 273 The European ME Research Group (EMERG) is a network of European researchers and researcher-clinicians 274 who formed to collaborate and share knowledge 275 in research into myalgic encephalomyelitis (ME, sometimes referred to as ME/CFS). 276 277 <br> 278 The group was formed in 2015 to create a strategy of high-quality, coordinated biomedical research that would 279 allow accumulation of data based on 280 collaboration and 281 sharing of experiences and knowledge, and aid identification of areas of research to form this strategy. 282 <br> 283 This assists in expanding the capacity of research in Europe 284 leading to progress in developing a rapid pathway for discovering the cause(s) of, 285 and treatment(s) for, ME. 286 287 </p><p class="lead"> 288 The development of new research and the accumulation of shared data based on collaboration 289 and experiences allows more rapid progress in the building of a foundation 290 of fundamental research into ME in Europe. 291 --> 292 <p class="mt-3 lead"> 293 294 The European ME Research Group (EMERG) is a network of European researchers and researcher-clinicians focused on 295 myalgic encephalomyelitis (ME, sometimes referred to as ME/CFS). 296 <br> 297 Formed in 2015, the group aims to create a strategy for high-quality, coordinated biomedical research. 298 <br> 299 This strategy emphasises collaboration and the sharing of experiences and knowledge to identify key research areas. 300 <p class="lead"> 301 The goal is to expand research capacity in Europe, accelerating the discovery of the cause(s) and treatment(s) for ME. 302 The development of new research and the accumulation of shared data build a foundation of fundamental ME research in Europe. 303 304 305 306 307 <!-- 308 <a href="em-aboutus.shtml"><button type="button" class="btn btn-outline btn-primary text-uppercase mt-4 mb-4 mb-md-0 font-weight-bold">read more</button></a> 309 --> 310 </p></div> 311 <div class="col-md-4"> 312 313 <img src="img/maps/imageedit_18_2473761295.png" class="mb-3 img-fluid box-shadow-custom"> 314 315 316 317 </div> 318 319 320 321 322 </div> 323 324 </div> 325 326 </div> 327 </div> 328 </div> 329 </div> 330 331<!----------------------------------------------------------------------------------------------------------------------------------------------------> 332<!--WHAT IS ME --> 333 <section class="bg-color-grey section-height-3 border-0 mt-5 mb-0" 334 style="background-image: url("
334img/demos/education/slides/slide-1-bg.jpg"); background-size: cover; 335 background-position: 100% 100%; "> 336 337 <div class="container"> 338 <div class="row center"> 339 <div class="container"> 340 341 <div class="col-md-11 mt-3 mb-3"> 342 343 <h4 class=" text-lg-8 font-weight-semibold line-height-1 "> 344 ME - What it IS⦠345 </h4> 346 347 348 349 350<div data-plugin-readmore="" data-plugin-options="{ 351 'buttonOpenLabel': 'Read More <i class=\'fas fa-chevron-down text-2 ms-1\'></i>', 352 'buttonCloseLabel': 'Read Less <i class=\'fas fa-chevron-up text-2 ms-1\'></i>', 353 'maxHeight': 200 354 }" class="position-relative" style="height: 200px; overflow-y: hidden;"> 355 356 357 <p class="lead"> 358Myalgic Encephalomyelitis (ME, sometimes referred to as ME/CFS) 359 is a serious, acquired, chronic, complex, and systemic disease associated with neurological, 360 immunological, autonomic, and energy metabolism dysfunction (Institute of Medicine, 2015). 361 Individuals with ME experience a range of symptoms including significant impairment in function, post-exertional malaise, sleep impairment, 362 cognitive issues, pain, orthostatic intolerance, flu-like symptoms, sensory intolerance, gastrointestinal and genitourinary issues. 363 364 365 <p class="lead"> 366 ME has been classified as a neurological disorder in the World Health Organisation's International Classification of Diseases under 367 Postviral Fatigue Syndrome (PVFS) 368 since 1969 (WHO code ICD 10 G93.3). 369 <br> 370 Since 1992, the term "Chronic Fatigue Syndrome" (CFS) has been included in the Alphabetical Index and indexed to G93.3 371 372 <br> 373In ICD-11, myalgic encephalomyelitis (ME) and chronic fatigue syndrome are 374classified under Chapter 8: Diseases of the Nervous System, within the code 3758E49 Postviral fatigue syndrome. 376 377<p class="lead"> 378 To date there is no known and universally accepted, specific medical diagnostic test to determine or confirm a correct diagnosis nor is there 379 any specific 380 treatment for this condition. 381 <br> 382 The cause(s) of ME are unknown, but many individuals with the disease remain ill after an acute 383 infection with symptoms that persist for six or more months. 384 385 <br> 386 There is currently no universally accepted diagnostic test or approved treatment for ME. 387 388 389 <br> 390 <p style="text-align: right"> 391 <a href="../whatisme.shtml" target="_blank"> 392 <button type="button" class="btn btn-outline btn-primary text-uppercase mt-4 mb-4 mb-md-0 font-weight-bold">Further information</button></a></p> 393 394 395 <div class="readmore-button-wrapper text-start" style="position: absolute; bottom: 0px; left: 0px; width: 100%; z-index: 2;"> 396 <a href="#" class="text-decoration-none">Read More <i class="fas fa-chevron-down text-2 ms-1"></i></a> 397 </div> 398 399<div class="readmore-overlay" style="background: linear-gradient(rgba(2, 0, 36, 0) 0%, rgb(255, 255, 255) 100%); position: absolute; bottom: 0px; left: 0px; width: 100%; height: 100px; z-index: 1; display: none;"> 400 401</div> 402 403</div> 404 405 406 407 408 409 410 411 </div> 412 </div> 413 </div> 414 415 <!-- 416 <center><a class="btn btn-borders btn-tertiary custom-button text-uppercase mt-lg font-weight-bold" href="Article-020 What is ME What is CFS.shtml" target="_blank">read more</a> 417 </center> 418 --> 419 420</div> 421 422 </section> 423 424 425 426 427 <div class="bg-grey-100 my-5 px-3 px-xl-0 border-radius-2 p-relative overflow-hidden"> 428 <div class="container "> 429 <div class="row "> 430 <div class="col"> 431 <!-- DESCRIPTION --------------------------------------------------------------------------------------------------------------------> 432 <h4 class=" text-lg-8 font-weight-semibold line-height-1 "> 433 434 Research and Clinical Practice Across Europe 435 436 </h4> 437 438 <div class="container pt-lg-3" id="intro"> 439 <div class="row align-items-center"> 440 <div class="col-lg-7 mb-5 mb-lg-0"> 441 <div class="appear-animation animated fadeInRightShorter appear-animation-visible" 442 data-appear-animation="fadeInRightShorter" data-appear-animation-delay="0" style="animation-delay: 0ms;"> 443 444 </div> 445 446 <div class=" " > 447 <p class="lead"> 448 449 Advancing the understanding and treatment of ME demands a comprehensive and collaborative approach. 450 This combines scientific expertise, 451 clinical practice, and patient advocacy to accelerate progress. 452 Key objectives include translating scientific discoveries 453 into clinical practice, amplifying patient voices, and building research capacity. 454 <p class="lead"> 455 Collaboration between researchers and clinicians facilitates the rapid integration of new findings into patient care. 456 Engaging with patient groups within the 457 European ME Alliance (EMEA) helps address the priorities and needs of those living with ME. Networks such as the 458 European ME Clinicians Council (EMECC) and Young EMERG support emerging talent and cultivate interest in ME 459 research among early-career researchers. 460 <p class="lead"> 461 Uniting these networks enables a collaborative environment that advances ME research and expedites improvements 462 in patient outcomes. This collective effort deepens the understanding and enhances the treatment of ME. 463 464 465 466 467 468 <div class="col-sm-9"> 469 <div class="modal fade" id="largeModal" tabindex="-1" aria-labelledby="largeModalLabel" aria-hidden="true" style="display: none;"> 470 <div class="modal-dialog modal-lg"> 471 <div class="modal-content"> 472 <div class="modal-header"> 473 <h4 class="modal-title" id="largeModalLabel"><b>European ME Research</b></h4> 474 <button type="button" class="btn-close" data-bs-dismiss="modal" aria-hidden="true">Ã</button> 475 </div> 476 <div class="modal-body"> 477 <p> 478 </p><h4><span style="color: #0099CC"><u><a href="https://europeanmeresearch.org/em-index.shtml" target="_blank">EMERG - European ME Research Group</a></u></span></h4> 479 <p class="lead text-4"> 480 a network of European ME researchers who formed to collaborate and share knowledge in research 481 into myalgic encephalomyelitis (ME) 482 </p> 483 <p> 484 </p><h4><span style="color: #0099CC"> <u>EMECC - European ME Clinicians Group</u> </span></h4> 485 <p class="lead text-4"> a network of clinicians treating ME patients and working together to 486 share expertise, 487 produce and maintain up-to-date diagnostic methods and assist researchers in building research into this disease. 488 </p> 489 490 <h4><span style="color: #0099CC"> <u><a href="https://www.europeanmealliance.org" target="_blank">EMEA - European ME Alliance</a></u> </span></h4> 491 <p class="lead text-4"> an alliance of European patient organisations 492 and charities who are involved in supporting patients suffering from 493 ME and campaigning for funding for biomedical research 494 to provide treatments and cures for ME, support of EMERG 495 </p> 496 <p> 497 </p><h4><span style="color: #0099CC"> <u><a href="https://youngemerg.com" target="_blank">YEMERG - Young European ME Research Group</a></u></span></h4> 498 <p class="lead text-4"> 499 a network of young/early career 500 European researchers that was formed to collaborate 501 and influence/build the future of research 502 into ME in Europe 503 </p> 504 </div> 505 <div class="modal-footer"> 506 <button type="button" class="btn btn-light" data-bs-dismiss="modal">Close</button> 507 </div> 508 </div> 509 </div> 510 </div> 511 </div> 512 </div> 513 514 </div> 515 <div class="col-lg-5 p-relative"> 516 <p style="text-align: center"> 517 <img src="../img/logos/eamerclogo4.png" width="190px" alt="" class="mt-0 img-fluid box-shadow-custom" 518 data-bs-toggle="modal" data-bs-target="#largeModal"></p> 519 <div class="accordion accordion-modern-status accordion-modern-status-arrow accordion-modern-status-arrow-dark mb-4 my-lg-4 pb-3 pb-lg-0" id="accordionWhoWeAre"> 520 <div class="card card-default box-shadow-8 border-radius-2 bg-light"> 521 <div class="card-header bg-transparent" id="collapseWhoWeAreHeadingOne"> 522 <h4 class="card-title m-0"> 523 <a class="accordion-toggle bg-transparent text-3-5 text-color-dark font-weight-semi-bold collapsed" data-bs-toggle="collapse" data-bs-target="#collapseWhoWeAreOne" aria-expanded="false" aria-controls="collapseWhoWeAreOne"> 524 EMECC Initiative 525 </a> 526 </h4> 527 </div> 528 <div id="collapseWhoWeAreOne" class="collapse" aria-labelledby="collapseWhoWeAreHeadingOne" data-bs-parent="#accordionWhoWeAre" style=""> 529 <div class="card-body pt-0"> 530 <p class="mb-0"> 531 The European ME Clinicians Council (EMECC) was established to create a network of 532 clinicians across Europe experienced in diagnosing and treating ME. 533 This initiative aimed to support clinicians, foster collaboration, and develop 534 standards and knowledge in partnership with researchers. Inspired by the US 535 Clinicians Council, EMECC was initiated by the UK charity Invest in ME Research 536 to collaborate with EMERG and the European ME Alliance (EMEA). 537 538 539 540 </p> 541 </div> 542 </div> 543 </div> 544 <div class="card card-default box-shadow-8 border-radius-2 bg-light"> 545 <div class="card-header bg-transparent" id="collapseWhoWeAreHeadingTwo"> 546 <h4 class="card-title m-0"> 547 <a class="accordion-toggle bg-transparent text-3-5 text-color-dark font-weight-semi-bold collapsed" data-bs-toggle="collapse" data-bs-target="#collapseWhoWeAreTwo" aria-expanded="false" aria-controls="collapseWhoWeAreTwo"> 548 EMEA Initiative for Patients 549 </a> 550 </h4> 551 </div> 552 <div id="collapseWhoWeAreTwo" class="collapse" aria-labelledby="collapseWhoWeAreHeadingTwo" data-bs-parent="#accordionWhoWeAre"> 553 <div class="card-body pt-0"> 554 <p class="mb-0"> 555 556 The European ME Alliance (EMEA) brings together patient organisations and charities 557 across Europe to advocate 558 for those affected by ME. EMEA advocates for patients, campaigns 559 for increased funding for biomedical research, and promotes 560 the need for better services and treatments. 561 By fostering collaboration and sharing experiences, EMEA works to raise awareness and drive progress in ME 562 research and patient care, supported by 563 the EMERG and EMECC. 564 565 </p> 566 </div> 567 </div> 568 </div> 569 <div class="card card-default box-shadow-8 border-radius-2 bg-light"> 570 <div class="card-header bg-transparent" id="collapseWhoWeAreHeadingThree"> 571 <h4 class="card-title m-0"> 572 <a class="accordion-toggle bg-transparent text-3-5 text-color-dark font-weight-semi-bold collapsed" data-bs-toggle="collapse" data-bs-target="#collapseWhoWeAreThree" aria-expanded="false" aria-controls="collapseWhoWeAreThree"> 573 Young EMERG Initiative 574 </a> 575 </h4> 576 </div> 577 <div id="collapseWhoWeAreThree" class="collapse" aria-labelledby="collapseWhoWeAreHeadingThree" data-bs-parent="#accordionWhoWeAre"> 578 <div class="card-body pt-0"> 579 <p class="mb-0"> 580 Young EMERG was established to support early-career researchers in the field of ME. 581 This initiative aims to foster the next generation of ME researchers by providing opportunities for 582 collaboration, career development, and capacity bu
582ilding. 583 By encouraging young scientists to engage in ME research, Young EMERG seeks to drive 584 innovation and ensure the future of 585 ME research in Europe, supported by the EMERG, EMECC and EMEA. 586 587 588 589 </p> 590 </div> 591 </div> 592 </div> 593 594 595 596 </div> 597 </div> 598 </div> 599 </div> 600 <a id="team"></a> 601 </div> 602 </div> 603 </div> 604 </div> 605 606 607 608 609 <div class="bg-grey-100 my-5 px-3 px-xl-0 border-radius-2 p-relative overflow-hidden"> 610 <div class="container "> 611 <div class="row "> 612 <div class="col"> 613 614 615<!----------------------------------------------------------------------------------------------------------------------------------------------------> 616<!--emerg team --> 617 618 619 620 <img src="img/fp/eurobannertxt.png" width="1702" height="642" class="img-fluid" alt=""> 621 622<!----------------------------------------------------------------------------------------------------------------------------------------------------> 623<!--emerg team --> 624<!-- include virtual="/00 Base-Common-Html/Base-Html-EMERG-team.html" --> 625 626<div class="accordion accordion-modern-status accordion-modern-status-arrow accordion-modern-status-arrow-dark" id="accordion2000"> 627 <div class="card card-default box-shadow-8"> 628 <div class="card-header" id="collapse2000HeadingOne"> 629 <h4 class="card-title m-0"> 630 <a class="accordion-toggle bg-light text-color-dark font-weight-bold collapsed" data-bs-toggle="collapse" 631 data-bs-target="#collapse2000One" aria-expanded="false" aria-controls="collapse2000One"> 632 View EMERG members 633 634 635 </a> 636 </h4> 637 </div> 638 <div id="collapse2000One" class="collapse" aria-labelledby="collapse2000HeadingOne" data-bs-parent="#accordion2000"> 639 <div class="card-body pt-0"> 640 641 <div class="row mt-lg-5"> 642 643 644 <div class="col-lg-2"> 645 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 646 href="#speaker-content-sc" data-plugin-options='{"type":"inline", preloader: false}'> 647 <div class="portfolio-item"> 648 <span class="thumb-info thumb-info-centered-info border-radius-0"> 649 <span class="thumb-info-wrapper border-radius-0"> 650 <img src="img/team/simoncarding.jpg" class="img-fluid border-radius-0" alt=""> 651 <span class="thumb-info-title"> 652 <span class="thumb-info-inner text-1">Simon Carding 653 <br> 654 co-chair, UK</span> 655 656 </span> 657 </span> 658 </span> 659 </div> 660 </a> 661 </div> 662 663 <div class="col-lg-2"> 664 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 665 href="#speaker-content-jm" data-plugin-options='{"type":"inline", preloader: false}'> 666 <div class="portfolio-item">
667 <span class="thumb-info thumb-info-centered-info border-radius-0"> 668 <span class="thumb-info-wrapper border-radius-0"> 669 <img src="img/team/jespermehlsen.jpg" class="img-fluid border-radius-0" alt=""> 670 <span class="thumb-info-title"> 671 <span class="thumb-info-inner text-1">Jesper Mehlsen 672 <br> 673 co-chair, Denmark</span> 674 </span> 675 </span> 676 </span> 677 </div> 678 </a> 679 </div> 680 681 <div class="col-lg-2"> 682 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 683 href="#speaker-content-ab" data-plugin-options='{"type":"inline", preloader: false}'> 684 <div class="portfolio-item"> 685 <span class="thumb-info thumb-info-centered-info border-radius-0"> 686 <span class="thumb-info-wrapper border-radius-0"> 687 <img src="../img/team/amolakbansal.jpg" class="img-fluid border-radius-0" alt=""> 688 <span class="thumb-info-title"> 689 <span class="thumb-info-inner text-1">Amolak Bansal 690 <br> 691 steering group, UK</span> 692 </span> 693 </span> 694 </span> 695 </div> 696 </a> 697 </div> 698 699 <div class="col-lg-2"> 700 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 701 href="#speaker-content-jb" data-plugin-options='{"type":"inline", preloader: false}'> 702 <div class="portfolio-item"> 703 <span class="thumb-info thumb-info-centered-info border-radius-0"> 704 <span class="thumb-info-wrapper border-radius-0"> 705 <img src="../img/team/jonasbergquist.jpg" class="img-fluid border-radius-0" alt=""> 706 <span class="thumb-info-title"> 707 <span class="thumb-info-inner text-1">Jonas Bergquist 708 <br> 709 steering group, Sweden</span> 710 </span> 711 </span> 712 </span> 713 </div> 714 </a> 715 </div> 716 717 <div class="col-lg-2"> 718 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 719 href="#speaker-content-pj" data-plugin-options='{"type":"inline", preloader: false}'> 720 <div class="portfolio-item"> 721 <span class="thumb-info thumb-info-centered-info border-radius-0">
722 <span class="thumb-info-wrapper border-radius-0"> 723 <img src="../img/team/perjulin.jpg" class="img-fluid border-radius-0" alt=""> 724 <span class="thumb-info-title"> 725 <span class="thumb-info-inner text-1">Per Julin 726 <br> 727 steering group, Sweden</span> 728 </span> 729 </span> 730 </span> 731 </div> 732 </a> 733 </div> 734 735 <div class="col-lg-2"> 736 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 737 href="#speaker-content-ak" data-plugin-options='{"type":"inline", preloader: false}'> 738 <div class="portfolio-item"> 739 <span class="thumb-info thumb-info-centered-info border-radius-0"> 740 <span class="thumb-info-wrapper border-radius-0"> 741 <img src="../img/team/alettakraneveld.jpg" class="img-fluid border-radius-0" alt=""> 742 <span class="thumb-info-title"> 743 <span class="thumb-info-inner text-1">Aletta Kraneveld 744 <br> 745 steering group, Netherlands</span> 746 </span> 747 </span> 748 </span> 749 </div> 750 </a> 751 </div> 752 753 <div class="col-lg-2"> 754 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 755 href="#speaker-content-eo" data-plugin-options='{"type":"inline", preloader: false}'> 756 <div class="portfolio-item"> 757 <span class="thumb-info thumb-info-centered-info border-radius-0"> 758 <span class="thumb-info-wrapper border-radius-0"> 759 <img src="../img/team/elisaoltra.jpg" class="img-fluid border-radius-0" alt=""> 760 <span class="thumb-info-title"> 761 <span class="thumb-info-inner text-1">Elisa Oltra 762 <br> 763 steering group, Spain</span> 764 </span> 765 </span> 766 </span> 767 </div> 768 </a> 769 </div> 770 771 <div class="col-lg-2"> 772 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 773 href="#speaker-content-mp" data-plugin-options='{"type":"inline", preloader: false}'> 774 <div class="portfolio-item"> 775 <span class="thumb-info thumb-info-centered-info border-radius-0"> 776 <span class="thumb-info-wrapper border-radius-0"> 777 <img src="../img/team/markkupartinen.jpg" class="img-fluid border-radius-0" alt="">
778 <span class="thumb-info-title"> 779 <span class="thumb-info-inner text-1">Markku Partinen 780 <br> 781 steering group, Finland</span> 782 </span> 783 </span> 784 </span> 785 </div> 786 </a> 787 </div> 788 789 <div class="col-lg-2"> 790 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 791 href="#speaker-content-ks" data-plugin-options='{"type":"inline", preloader: false}'> 792 <div class="portfolio-item"> 793 <span class="thumb-info thumb-info-centered-info border-radius-0"> 794 <span class="thumb-info-wrapper border-radius-0"> 795 <img src="../img/team/kristiansommerfelt.jpg" class="img-fluid border-radius-0" alt=""> 796 <span class="thumb-info-title"> 797 <span class="thumb-info-inner text-1">Kristian Sommerfelt 798 <br> 799 steering group, Norway</span> 800 </span> 801 </span> 802 </span> 803 </div> 804 </a> 805 </div> 806 807 <div class="col-lg-2"> 808 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 809 href="#speaker-content-tw" data-plugin-options='{"type":"inline", preloader: false}'> 810 <div class="portfolio-item"> 811 <span class="thumb-info thumb-info-centered-info border-radius-0"> 812 <span class="thumb-info-wrapper border-radius-0"> 813 <img src="../img/team/tomwileman.jpg" class="img-fluid border-radius-0" alt=""> 814 <span class="thumb-info-title"> 815 <span class="thumb-info-inner text-1">Tom Wileman 816 <br> 817 steering group, UK</span> 818 </span> 819 </span> 820 </span> 821 </div> 822 </a> 823 </div> 824 825 826 <div class="col-lg-2"> 827 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 828 href="#speaker-content-jbo" data-plugin-options='{"type":"inline", preloader: false}'> 829 <div class="portfolio-item"> 830 <span class="thumb-info thumb-info-centered-info border-radius-0"> 831 <span class="thumb-info-wrapper border-radius-0"> 832 <img src="img/team/josbosch.png" class="img-fluid border-radius-0" alt=""> 833 <span class="thumb-info-title"> 834 <sp
834an class="thumb-info-inner text-1">Jos Bosch 835 <br> 836 Netherlands 837 </span> 838 </span> 839 </span> 840 </span> 841 </div> 842 </a> 843 </div> 844 845 846 <div class="col-lg-2"> 847 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 848 href="#speaker-content-bdj" data-plugin-options='{"type":"inline", preloader: false}'> 849 <div class="portfolio-item"> 850 <span class="thumb-info thumb-info-centered-info border-radius-0"> 851 <span class="thumb-info-wrapper border-radius-0"> 852 <img src="../img/team/beata.png" class="img-fluid border-radius-0" alt="beata"> 853 <span class="thumb-info-title"> 854 <span class="thumb-info-inner text-1"> Beata Dela-Jawaorska 855 <br> 856 UK</span> 857 858 859 </span> 860 </span> 861 </span> 862 </div> 863 </a> 864 </div> 865 866 867 <div class="col-lg-2"> 868 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 869 href="#speaker-content-tk" data-plugin-options='{"type":"inline", preloader: false}'> 870 <div class="portfolio-item"> 871 <span class="thumb-info thumb-info-centered-info border-radius-0"> 872 <span class="thumb-info-wrapper border-radius-0"> 873 <img src="../img/team/teklakarlsdottir.jpg" class="img-fluid border-radius-0" alt=""> 874 <span class="thumb-info-title"> 875 <span class="thumb-info-inner text-1"> Tekla H. Karlsdottir 876 <br> 877 Iceland</span> 878 879 880 </span> 881 </span> 882 </span> 883 </div> 884 </a> 885 </div> 886 887 <div class="col-lg-2"> > 888 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 889 href="#speaker-content-bl" data-plugin-options='{"type":"inline", preloader: false}'> 890 <div class="portfolio-item"> 891 <span class="thumb-info thumb-info-centered-info border-radius-0"> 892 <span class="thumb-info-wrapper border-radius-0"> 893 <img src="../img/team/benedictelie.jpg" class="img-fluid border-radius-0" alt=""> 894 <span class="thumb-info-title">
895 <span class="thumb-info-inner text-1">Benedicte Lie 896 <br> 897 Norway</span> 898 </span> 899 </span> 900 </span> 901 </div> 902 </a> 903 </div> 904 905 <div class="col-lg-2"> 906 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 907 href="#speaker-content-em" data-plugin-options='{"type":"inline", preloader: false}'> 908 <div class="portfolio-item"> 909 <span class="thumb-info thumb-info-centered-info border-radius-0"> 910 <span class="thumb-info-wrapper border-radius-0"> 911 <img src="../img/team/evamartin2.jpg" class="img-fluid border-radius-0" alt=""> 912 <span class="thumb-info-title"> 913 <span class="thumb-info-inner text-1">Eva Martin 914 <br> 915 Spain</span> 916 </span> 917 </span> 918 </span> 919 </div> 920 </a> 921 </div> 922 923 <div class="col-lg-2"> 924 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 925 href="#speaker-content-sm" data-plugin-options='{"type":"inline", preloader: false}'> 926 <div class="portfolio-item"> 927 <span class="thumb-info thumb-info-centered-info border-radius-0"> 928 <span class="thumb-info-wrapper border-radius-0"> 929 <img src="../img/team/simonmcarthur.jpg" class="img-fluid border-radius-0" alt=""> 930 <span class="thumb-info-title"> 931 <span class="thumb-info-inner text-1">Simon McArthur 932 <br> 933 UK</span> 934 </span> 935 </span> 936 </span> 937 </div> 938 </a> 939 </div> 940 941 <div class="col-lg-2"> 942 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 943 href="#speaker-content-bm" data-plugin-options='{"type":"inline", preloader: false}'> 944 <div class="portfolio-item"> 945 <span class="thumb-info thumb-info-centered-info border-radius-0"> 946 <span class="thumb-info-wrapper border-radius-0"> 947 <img src="../img/team/branislav.jpg" class="img-fluid border-radius-0" alt=""> 948 <span class="thumb-info-title"> 949 <span class="thumb-info-inner text-1">BRANISLAV MILOVANOVIÄ 950 <br>
951 Serbia</span> 952 </span> 953 </span> 954 </span> 955 </div> 956 </a> 957 </div> 958 959 <div class="col-lg-2"> 960 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 961 href="#speaker-content-ro" data-plugin-options='{"type":"inline", preloader: false}'> 962 <div class="portfolio-item"> 963 <span class="thumb-info thumb-info-centered-info border-radius-0"> 964 <span class="thumb-info-wrapper border-radius-0"> 965 <img src="../img/team/rikkeolsen.jpg" class="img-fluid border-radius-0" alt=""> 966 <span class="thumb-info-title"> 967 <span class="thumb-info-inner text-1">Rikke Olsen 968 <br> 969 Denmark</span> 970 </span> 971 </span> 972 </span> 973 </div> 974 </a> 975 </div> 976 977 978 <div class="col-lg-2"> 979 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 980 href="#speaker-content-cp" data-plugin-options='{"type":"inline", preloader: false}'> 981 <div class="portfolio-item"> 982 <span class="thumb-info thumb-info-centered-info border-radius-0"> 983 <span class="thumb-info-wrapper border-radius-0"> 984 <img src="../img/team/carmenpichot.png" class="img-fluid border-radius-0" alt=""> 985 <span class="thumb-info-title"> 986 <span class="thumb-info-inner text-1">Carmen Pichot 987 <br> 988 Sweden</span> 989 </span> 990 </span> 991 </span> 992 </div> 993 </a> 994 </div> 995 996 <div class="col-lg-2"> 997 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 998 href="#speaker-content-pp" data-plugin-options='{"type":"inline", preloader: false}'> 999 <div class="portfolio-item"> 1000 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1001 <span class="thumb-info-wrapper border-radius-0"> 1002 <img src="../img/team/pennypowell.jpg" class="img-fluid border-radius-0" alt=""> 1003 <span class="thumb-info-title"> 1004 <span class="thumb-info-inner text-1">Penny Powell 1005 <br> 1006 UK</span> 1007 </span> 1008 </span> 1009 </span> 1010 </div> 1011 </a> 1012 </div> 1013 1014 <div class="col-lg-2"> 1015 <a class="lightbox text-2 thumb-info-lighten thumb
1015-info-bottom-info thumb-info-centered-icons" 1016 href="#speaker-content-ar" data-plugin-options='{"type":"inline", preloader: false}'> 1017 <div class="portfolio-item"> 1018 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1019 <span class="thumb-info-wrapper border-radius-0"> 1020 <img src="../img/team/andersrosen.jpg" class="img-fluid border-radius-0" alt=""> 1021 <span class="thumb-info-title"> 1022 <span class="thumb-info-inner text-1">Anders RosÃn 1023 <br> 1024 Sweden</span> 1025 </span> 1026 </span> 1027 </span> 1028 </div> 1029 </a> 1030 </div> 1031 1032 1033 1034 1035 <div class="col-lg-2"> 1036 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1037 href="#speaker-content-os" data-plugin-options='{"type":"inline", preloader: false}'> 1038 1039 <div class="portfolio-item"> 1040 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1041 <span class="thumb-info-wrapper border-radius-0"> 1042 <img src="../img/team/olasaugstad.jpg" class="img-fluid border-radius-0" alt=""> 1043 <span class="thumb-info-title"> 1044 <span class="thumb-info-inner text-1">Ola Didrik Saugstad 1045 <br> 1046 Norway</span> 1047 </span> 1048 </span> 1049 </span> 1050 </div> 1051 </a> 1052 </div> 1053 1054 1055 <div class="col-lg-2"> 1056 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1057 href="#speaker-content-ls" data-plugin-options='{"type":"inline", preloader: false}'> 1058 <div class="portfolio-item"> 1059 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1060 <span class="thumb-info-wrapper border-radius-0"> 1061 <img src="img/team/lutzschomburg.png" class="img-fluid border-radius-0" alt=""> 1062 <span class="thumb-info-title"> 1063 <span class="thumb-info-inner text-1">Lutz Schomburg 1064 <br> 1065 Germany</span> 1066 </span> 1067 </span> 1068 </span> 1069 </div> 1070 </a> 1071 </div> 1072 1073 <div class="col-lg-2"> 1074 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1075 href="#speaker-content-kris" data-plugin-options='{"type":"inline", preloader: false}'> 1076 <div class="portfolio-item">
1077 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1078 <span class="thumb-info-wrapper border-radius-0"> 1079 <img src="../img/team/kristin.png" class="img-fluid border-radius-0" alt=""> 1080 <span class="thumb-info-title"> 1081 <span class="thumb-info-inner text-1">KRISTÃN SIGURÃARDÃTTIR 1082 <br> 1083 Iceland</span> 1084 </span> 1085 </span> 1086 </span> 1087 </div> 1088 </a> 1089 </div> 1090 1091 <div class="col-lg-2"> 1092 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1093 href="#speaker-content-fs" data-plugin-options='{"type":"inline", preloader: false}'> 1094 <div class="portfolio-item"> 1095 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1096 <span class="thumb-info-wrapper border-radius-0"> 1097 <img src="../img/team/fridbjornsigurdsson.jpg" class="img-fluid border-radius-0" alt=""> 1098 <span class="thumb-info-title"> 1099 <span class="thumb-info-inner text-1">FRIÃBJÃRN SIGURDSSON 1100 <br> 1101 1102 Iceland</span> 1103 </span> 1104 </span> 1105 </span> 1106 </div> 1107 </a> 1108 </div> 1109 <div class="col-lg-2"> 1110 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1111 href="#speaker-content-lsk" data-plugin-options='{"type":"inline", preloader: false}'> 1112 <div class="portfolio-item"> 1113 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1114 <span class="thumb-info-wrapper border-radius-0"> 1115 <img src="../img/team/linn.png" class="img-fluid border-radius-0" alt="linn"> 1116 <span class="thumb-info-title"> 1117 <span class="thumb-info-inner text-1">Linn Skjevling 1118 <br> 1119 Norway</span> 1120 </span> 1121 </span> 1122 </span> 1123 </div> 1124 </a> 1125 </div> 1126 1127 <div class="col-lg-2"> 1128 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1129 href="#speaker-content-kjt" data-plugin-options='{"type":"inline", preloader: false}'> 1130 <div class="portfolio-item"> 1131 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1132 <span class="thumb-info-wrapper border-radius-0"> 1133 <img src="../img/team/karlj.png" class="img-fluid border-radius-0" alt="">
1134 <span class="thumb-info-title"> 1135 <span class="thumb-info-inner text-1">Karl Johan Tronstad 1136 <br> 1137 Norway</span> 1138 </span> 1139 </span> 1140 </span> 1141 </div> 1142 </a> 1143 </div> 1144 1145 <div class="col-lg-2"> 1146 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1147 href="#speaker-content-mv" data-plugin-options='{"type":"inline", preloader: false}'> 1148 <div class="portfolio-item"> 1149 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1150 <span class="thumb-info-wrapper border-radius-0"> 1151 <img src="../img/team/marteviken.jpg" class="img-fluid border-radius-0" alt=""> 1152 <span class="thumb-info-title"> 1153 <span class="thumb-info-inner text-1">Marte Viken 1154 <br> 1155 Norway</span> 1156 </span> 1157 </span> 1158 </span> 1159 </div> 1160 </a> 1161 </div> 1162 1163 <div class="col-lg-2"> 1164 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1165 href="#speaker-content-tv" data-plugin-options='{"type":"inline", preloader: false}'> 1166 <div class="portfolio-item"> 1167 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1168 <span class="thumb-info-wrapper border-radius-0"> 1169 <img src="img/team/thomasvogl.png" class="img-fluid border-radius-0" alt=""> 1170 <span class="thumb-info-title"> 1171 <span class="thumb-info-inner text-1">Thomas Vogl 1172 <br> 1173 Austria</span> 1174 </span> 1175 </span> 1176 </span> 1177 </div> 1178 </a> 1179 </div> 1180 1181 1182 <div class="col-lg-2"> 1183 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1184 href="#speaker-content-ht" data-plugin-options='{"type":"inline", preloader: false}'> 1185 <div class="portfolio-item"> 1186 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1187 <span class="thumb-info-wrapper border-radius-0"> 1188 <img src="img/team/hatice.jpg" class="img-fluid border-radius-0" alt=""> 1189 <span class="thumb-info-title"> 1190 <span class="thumb-info-inner text-1">Hatice Tankisi <br> 1191 <br> 1192 Denmark 1193 </span> 1194 </span> 1195 </span> 1196 </span> 1197 </div> 1198 </a> 1199 </div> 1200 1201 1202 1203 <div class="col-lg-2"> 1204 <a class="lightbox text-2 thumb-info-lighten thumb
1204-info-bottom-info thumb-info-centered-icons" 1205 href="#speaker-content-sts" data-plugin-options='{"type":"inline", preloader: false}'> 1206 <div class="portfolio-item"> 1207 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1208 <span class="thumb-info-wrapper border-radius-0"> 1209 <img src="../img/team/sigurveig2.jpg" class="img-fluid border-radius-0" alt=""> 1210 <span class="thumb-info-title"> 1211 <span class="thumb-info-inner text-1">Sigurveig T Sigurdardottir 1212 <br> 1213 Iceland 1214 </span> 1215 </span> 1216 </span> 1217 </span> 1218 </div> 1219 </a> 1220 </div> 1221 1222 1223 1224 <div class="col-lg-2"> 1225 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1226 href="#speaker-content-ke" data-plugin-options='{"type":"inline", preloader: false}'> 1227 <div class="portfolio-item"> 1228 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1229 <span class="thumb-info-wrapper border-radius-0"> 1230 <img src="../img/team/kristianE.jpg" class="img-fluid border-radius-0" alt=""> 1231 <span class="thumb-info-title"> 1232 <span class="thumb-info-inner text-1">Kristjan Erlendsson 1233 <br> 1234 Iceland 1235 </span> 1236 </span> 1237 </span> 1238 </span> 1239 </div> 1240 </a> 1241 </div> 1242 1243 1244 1245 <div class="col-lg-2"> 1246 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1247 href="#speaker-content-eue" data-plugin-options='{"type":"inline", preloader: false}'> 1248 <div class="portfolio-item"> 1249 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1250 <span class="thumb-info-wrapper border-radius-0"> 1251 <img src="../img/team/evau.jpg" class="img-fluid border-radius-0" alt=""> 1252 <span class="thumb-info-title"> 1253 <span class="thumb-info-inner text-1">Eva Untersmayr-Elsenhuber 1254 <br> 1255 Austria 1256 </span> 1257 </span> 1258 </span> 1259 </span> 1260 </div> 1261 </a> 1262 </div> 1263 1264 1265 1266 <div class="col-lg-2"> 1267 <a class="lightbox text-2 thumb-info-lighten thumb
1267-info-bottom-info thumb-info-centered-icons" 1268 href="#speaker-content-dpr" data-plugin-options='{"type":"inline", preloader: false}'> 1269 <div class="portfolio-item"> 1270 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1271 <span class="thumb-info-wrapper border-radius-0"> 1272 <img src="../img/team/davidprice.png" class="img-fluid border-radius-0" alt=""> 1273 <span class="thumb-info-title"> 1274 <span class="thumb-info-inner text-1">David Price 1275 <br> 1276 UK 1277 </span> 1278 </span> 1279 </span> 1280 </span> 1281 </div> 1282 </a> 1283 </div> 1284 1285 1286 <div class="col-lg-2"> 1287 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1288 href="#speaker-content-cd" data-plugin-options='{"type":"inline", preloader: false}'> 1289 <div class="portfolio-item"> 1290 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1291 <span class="thumb-info-wrapper border-radius-0"> 1292 <img src="../img/team/Caroline%20Dalton%20119807.jpg" class="img-fluid border-radius-0" alt=""> 1293 <span class="thumb-info-title"> 1294 <span class="thumb-info-inner text-1">Caroline Dalton 1295 <br> 1296 UK 1297 </span> 1298 </span> 1299 </span> 1300 </span> 1301 </div> 1302 </a> 1303 </div> 1304 1305 1306 1307 <div class="col-lg-2"> 1308 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1309 href="#speaker-content-cecilia" data-plugin-options='{"type":"inline", preloader: false}'> 1310 <div class="portfolio-item"> 1311 <span class="thumb-info thumb-info-centered-info border-radius-0"> 1312 <span class="thumb-info-wrapper border-radius-0"> 1313 <img src="../img/team/cecilia.png" class="img-fluid border-radius-0" alt=""> 1314 <span class="thumb-info-title"> 1315 <span class="thumb-info-inner text-1">Cecilia Tibell 1316 <br> 1317 Sweden 1318 </span> 1319 </span> 1320 </span> 1321 </span> 1322 </div> 1323 </a> 1324 </div> 1325 1326 </div> 1327 1328 1329 1330 1331 </div> 1332 </div> 1333 </div> 1334 1335 1336 1337</div> 1338 1339 1340 <a id="research"></a> 1341 </div> 1342 </div> 1343 </div> 1344 </div> 1345 1346 1347 1348 1349 1350 1351 1352 <div class="bg-grey-100 my-5 px-3 px-xl-0 border-radius-2 p-relative overflow-hidden"> 1353 <div class="container "> 1354 <div class="row "> 1355 <div class="col"> 1356 <h4 class=" text-lg-8 font-weight-semibold line-height-1 "> 1357 1358 Member Research Activities 1359 1360 </h4> 1361 1362 <p class="lead"> 1363 EMERG members across Europe are engaged in various activities to advance ME research and clinical practice. The
1363se activities include collaborative research projects and supporting early career researchers through Young EMERG. These efforts aim to translate 1364 scientific discoveries into clinical advancements and build research capacity to improve patient outcomes. 1365 1366 1367<div class="bg-grey-100 px-3 px-xl-0 border-radius-2-bottom p-relative overflow-hidden"> 1368 <div class="container "> 1369 <div class="row "> 1370 1371 1372 <div class="col-lg-1 mb-4 pb-1"> 1373 </div> 1374 <div class="col-lg-2 mb-4 pb-1"> 1375 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1376 href="#act-austria" data-plugin-options='{"type":"inline", preloader: false}'> 1377 <article class="post"> 1378 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover anim-hover-translate-top-10px transition-3ms"> 1379 <div class="p-relative rounded-3 overflow-hidden"> 1380 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1381 href="#act-austria" data-plugin-options='{"type":"inline", preloader: false}'> 1382 <img class="card-img-top" src="img/flags/flag-austria-with-ensign.jpg" 1383 loading="lazy" alt="Card Image"> 1384 </a> 1385 <div class="card-body bg-light p-4"> 1386 <h4 class="my-2"> 1387 Austria 1388 </h4> 1389 1390 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons 1391 read-more text-color-secondary font-weight-semibold text-2" 1392 href="#act-austria" data-plugin-options='{"type":"inline", preloader: false}'> 1393 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1394 1395 </div> 1396 </div> 1397 </div> 1398 </article> 1399 </a> 1400 </div> 1401 1402 <div class="col-lg-2 mb-4 pb-1"> 1403 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1404 href="#act-denmark" data-plugin-options='{"type":"inline", preloader: false}'> 1405 <article class="post"> 1406 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover anim-hover-translate-top-10px transition-3ms"> 1407 <div class="p-relative rounded-3 overflow-hidden"> 1408 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1409 href="#act-denmark" data-plugin-options='{"type":"inline", preloader: false}'> 1410 <img class="card-img-top" src="img/flags/denmark.png" loading="lazy" alt="Card Image"> 1411 </a> 1412 <div class="card-body bg-light p-4"> 1413 <h4 class="my-2"> Denmark </h4> 1414 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb
1414-info-bottom-info thumb-info-centered-icons 1415 read-more text-color-secondary font-weight-semibold text-2" 1416 href="#act-denmark" data-plugin-options='{"type":"inline", preloader: false}'> 1417 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1418 </div> 1419 </div> 1420 </div> 1421 </article> 1422 </a> 1423 </div> 1424 <div class="col-lg-2 mb-4 pb-1"> 1425 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1426 href="#act-iceland" data-plugin-options='{"type":"inline", preloader: false}'> 1427 <article class="post"> 1428 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover anim-hover-translate-top-10px transition-3ms"> 1429 <div class="p-relative rounded-3 overflow-hidden"> 1430 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1431 href="#act-iceland" data-plugin-options='{"type":"inline", preloader: false}'> 1432 <img class="card-img-top" src="img/flags/iceland.png" loading="lazy" alt="Card Image"> 1433 </a> 1434 <div class="card-body bg-light p-4"> 1435 <h4 class="my-2"> Iceland </h4> 1436 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons 1437 read-more text-color-secondary font-weight-semibold text-2" 1438 href="#act-iceland" data-plugin-options='{"type":"inline", preloader: false}'> 1439 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1440 </div> 1441 </div> 1442 </div> 1443 </article> 1444 </a> 1445 </div> 1446 1447 1448 1449 <div class="col-lg-2 mb-4 pb-1"> 1450 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1451 href="#act-netherlands" data-plugin-options='{"type":"inline", preloader: false}'> 1452 <article class="post"> 1453 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover 1454 anim-hover-translate-top-10px transition-3ms"> 1455 <div class="p-relative rounded-3 overflow-hidden"> 1456 1457 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb-info-bottom-info 1458 thumb-info-centered-icons" 1459 href="#act-netherlands" data-plugin-options='{"type":"inline", preloader: false}'> 1460 <img class="card-img-top" src="img/flags/netherlands.jpg" loading="lazy" alt="Card Image"> 1461 </a> 1462 1463 <div class="card-body bg-light p-4"> 1464 <h4 class="my-2"> Netherlands </h4> 1465 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb
1465-info-bottom-info thumb-info-centered-icons 1466 read-more text-color-secondary font-weight-semibold text-2" 1467 href="#act-netherlands" data-plugin-options='{"type":"inline", preloader: false}'> 1468 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1469 </div> 1470 </div> 1471 </div> 1472 </article> </a> 1473 </div> 1474 <div class="col-lg-2 mb-4 pb-1"> 1475 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1476 href="#act-norway" data-plugin-options='{"type":"inline", preloader: false}'> 1477 <article class="post"> 1478 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover anim-hover-translate-top-10px transition-3ms"> 1479 <div class="p-relative rounded-3 overflow-hidden"> 1480 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1481 href="#act-norway" data-plugin-options='{"type":"inline", preloader: false}'> 1482 <img class="card-img-top" src="img/flags/norway.png" 1483 loading="lazy" alt="Card Image"> 1484 </a> 1485 <div class="card-body bg-light p-4"> 1486 <h4 class="my-2"> 1487 Norway 1488 </h4> 1489 1490 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons 1491 read-more text-color-secondary font-weight-semibold text-2" 1492 href="#act-norway" data-plugin-options='{"type":"inline", preloader: false}'> 1493 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1494 1495 </div> 1496 </div> 1497 </div> 1498 </article> 1499 </a> 1500 </div> 1501 1502 <div class="col-lg-1 mb-4 pb-1"> 1503 </div> 1504 1505 <div class="col-lg-1 mb-4 pb-1"> 1506 </div> 1507 <div class="col-lg-2 mb-4 pb-1"> 1508 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1509 href="#act-germany" data-plugin-options='{"type":"inline", preloader: false}'> 1510 <article class="post"> 1511 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover anim-hover-translate-top-10px transition-3ms"> 1512 <div class="p-relative rounded-3 overflow-hidden"> 1513 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1514 href="#act-germany" data-plugin-options='{"type":"inline", preloader: false}'> 1515 <img class="card-img-top" src="img/flags/germany.jpg" 1516 loading="lazy" alt="Card Image"> 1517 </a> 1518 <div class="card-body bg-light p-4"> 1519 <h4 class="my-2"> 1520 Germany 1521 </h4> 1522 1523 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb
1523-info-bottom-info thumb-info-centered-icons 1524 read-more text-color-secondary font-weight-semibold text-2" 1525 href="#act-germany" data-plugin-options='{"type":"inline", preloader: false}'> 1526 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1527 1528 </div> 1529 </div> 1530 </div> 1531 </article> 1532 </a> 1533 </div> 1534 <div class="col-lg-2 mb-4 pb-1"> 1535 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1536 href="#act-serbia" data-plugin-options='{"type":"inline", preloader: false}'> 1537 <article class="post"> 1538 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover anim-hover-translate-top-10px transition-3ms"> 1539 <div class="p-relative rounded-3 overflow-hidden"> 1540 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1541 href="#act-serbia" data-plugin-options='{"type":"inline", preloader: false}'> 1542 <img class="card-img-top" src="img/flags/serbia1.png" 1543 loading="lazy" alt="Card Image"> 1544 </a> 1545 <div class="card-body bg-light p-4"> 1546 <h4 class="my-2"> 1547 Serbia 1548 </h4> 1549 1550 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons 1551 read-more text-color-secondary font-weight-semibold text-2" 1552 href="#act-serbia" data-plugin-options='{"type":"inline", preloader: false}'> 1553 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1554 1555 </div> 1556 </div> 1557 </div> 1558 </article> 1559 </a> 1560 </div> 1561 <div class="col-lg-2 mb-4 pb-1"> 1562 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1563 href="#act-spain" data-plugin-options='{"type":"inline", preloader: false}'> 1564 <article class="post"> 1565 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover anim-hover-translate-top-10px transition-3ms"> 1566 <div class="p-relative rounded-3 overflow-hidden"> 1567 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1568 href="#act-spain" data-plugin-options='{"type":"inline", preloader: false}'> 1569 <img class="card-img-top" src="img/flags/spain.png" 1570 loading="lazy" alt="Card Image"> 1571 </a> 1572 <div class="card-body bg-light p-4"> 1573 <h4 class="my-2"> 1574 Spain 1575 </h4> 1576 1577 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb
1577-info-bottom-info thumb-info-centered-icons 1578 read-more text-color-secondary font-weight-semibold text-2" 1579 href="#act-spain" data-plugin-options='{"type":"inline", preloader: false}'> 1580 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1581 1582 </div> 1583 </div> 1584 </div> 1585 </article> 1586 </a> 1587 </div> 1588 <div class="col-lg-2 mb-4 pb-1"> 1589 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1590 href="#act-sweden" data-plugin-options='{"type":"inline", preloader: false}'> 1591 <article class="post"> 1592 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover anim-hover-translate-top-10px transition-3ms"> 1593 <div class="p-relative rounded-3 overflow-hidden"> 1594 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1595 href="#act-sweden" data-plugin-options='{"type":"inline", preloader: false}'> 1596 <img class="card-img-top" src="img/flags/sweden.png" 1597 loading="lazy" alt="Card Image"> 1598 </a> 1599 <div class="card-body bg-light p-4"> 1600 <h4 class="my-2"> 1601 Sweden 1602 </h4> 1603 1604 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons 1605 read-more text-color-secondary font-weight-semibold text-2" 1606 href="#act-sweden" data-plugin-options='{"type":"inline", preloader: false}'> 1607 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1608 1609 </div> 1610 </div> 1611 </div> 1612 </article> 1613 </a> 1614 </div> 1615 <div class="col-lg-2 mb-4 pb-1"> 1616 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1617 href="#act-uk" data-plugin-options='{"type":"inline", preloader: false}'> 1618 <article class="post"> 1619 <div class="card rounded-3 border-0 bg-transparent box-shadow-10 box-shadow-1 box-shadow-1-hover anim-hover-translate-top-10px transition-3ms"> 1620 <div class="p-relative rounded-3 overflow-hidden"> 1621 <a class="lightbox text-2 thumb-info-lighten thumb-info-bottom-info thumb-info-centered-icons" 1622 href="#act-uk" data-plugin-options='{"type":"inline", preloader: false}'> 1623 <img class="card-img-top" src="img/flags/uk.png" 1624 loading="lazy" alt="Card Image"> 1625 </a> 1626 <div class="card-body bg-light p-4"> 1627 <h4 class="my-2"> 1628 UK 1629 </h4> 1630 1631 <a class="text-decoration-none lightbox text-2 thumb-info-lighten thumb
1631-info-bottom-info thumb-info-centered-icons 1632 read-more text-color-secondary font-weight-semibold text-2" 1633 href="#act-uk" data-plugin-options='{"type":"inline", preloader: false}'> 1634 Read More <i class="fas fa-angle-right position-relative top-1 ms-1"></i></a> 1635 1636 </div> 1637 </div> 1638 </div> 1639 </article> 1640 </a> 1641 </div> 1642 1643 <div class="col-lg-1 mb-4 pb-1"> 1644 </div> 1645 1646 1647 </div> 1648 1649 </div> 1650 </div> 1651 1652 1653<!-- Speaker Lightbox Austria --> 1654<div id="act-austria" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 1655 <div class="row"> 1656 1657 <!-- <img src="../img/flags/flag-austria-with-ensign.jpg" class="img-fluid mb-2" width="190px"/> 1658 --> 1659 1660 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in Austria</h2> 1661 1662 <h4>Thomas Vogl </h4> 1663 1664Thomas Vogl's research centres on the intricate interplay between the immune system and microbes in cancer, with a particular focus on how 1665the gut microbiome influences the immune system's response to cancer therapies.<br> 1666His work combines biological experiments with computer-assisted analyses to delve into these complex interactions, aiming to improve cancer 1667prevention strategies and develop novel therapies.<br> 1668In the realm of ME research, Vogl's team is actively investigating the role of the microbiome in Long COVID, seeking to identify 1669biomarkers that could shed light on the condition's mechanisms and potential treatments.<br> 1670His research is supported by substantial funding, including an ERC Starting Grant of â¬1.65 million and the "Global Grant for Gut Health" 1671from Nature Research Awards, which specifically supports his work on the gut microbiome's role in Long COVID.<br> 1672Additionally, Vogl coordinates the EU Horizon Health consortium âID-DarkMatter-NCDâ and is a partner in the ZonMW ME/CFS Lines consortium, 1673 further emphasising his commitment to advancing ME research. 1674 1675<br> 1676<br> <h4>Eva Untersmayr-Elsenhuber</h4> 1677<br>Eva Untersmayr-Elsenhuber's research focuses on clinical immunology, particularly the mucosal barrier and its role in protecting the body 1678from pathogens and modulating the immune response.<br> 1679 1680Her work also includes studies on the skin microbiota and its influence on skin health and diseases. Untersmayr-Elsenhuber has contributed to 1681 a D-A-CH consensus statement on the diagnosis and treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), aiming to 1682 summarise current knowledge and highlight diagnostic criteria.<br>< 1683 1684In the realm of ME research, Untersmayr-Elsenhuber's contributions emphasise the importance of understanding the skin microbiota's role in 1685maintaining health and preventing diseases, which is crucial for ME/CFS patients who often experience skin-related symptoms.<br> 1686 1687Her research is supported by access to clinical data and collaborations with researchers in immunology and microbiota. 1688 1689 1690 1691 1692 1693 1694 </div> 1695</div> 1696 1697 1698 1699 1700 1701 1702 1703 <!-- Speaker Lightbox Denmark --> 1704<div id="act-denmark" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 1705 <div class="row"> 1706 <!-- 1707 <img src="../img/flags/denmark.png" class="img-fluid mb-2" width="190px"/> 1708 --> 1709 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in Denmark</h2> 1710 <p> 1711<br>Current ME Research in Denmark 1712 1713<br> Jesper Mehlsen 1714 1715Jesper Mehlsen's research focuses on the autonomic nervous system and complex diseases, including those potentially resulting from HPV vaccines.<br> 1716 1717He specialises in investigating autonomic dysfunction, which can lead to symptoms such as orthostatic intolerance and cognitive dysfunction, common 1718 in ME/CFS.<br> 1719 1720In the realm of ME research, Mehlsen has been a vocal advocate for treating ME/CFS as a physical, neurological illness rather than a 1721psychosomatic condition. He has contributed to policy changes in Denmark, helping to separate ME from functional disorders and acknowledging 1722 the inadequacy of current treatments.<br> > 1723 1724His research is supported by access to clinical data and collaborations with other researchers and clinicians in the field of ME/CFS. 1725 While specific funding details for ME research are not explicitly mentioned, his broader research is likely supported by 1726 various grants and 1727 institutional funding. 1728<br> <br> 1729 1730Rikke Olsen <br> 1731Rikke Olsen's research focuses on the role of mitochondria in health and disease, particularly in the context of neurological disorders.<br> 1732 1733Her work investigates how mitochondrial dysfunction contributes to the pathophysiology of various conditions, including those that may 1734overlap with symptoms experienced by ME/CFS patients.<br> 1735 1736In the realm of ME research, Olsen's contributions to understanding mitochondrial function could provide valuable insights into the 1737 energy production deficits and fatigue often reported by ME/CFS patients.<br> 1738 1739Her research is supported by various grants and institutional funding, and she collaborates with other researchers in the field of 1740 mitochondrial biology and neuroscience.<br> 1741 1742Olsen's work on mitochondria offers a crucial perspective on the cellular mechanisms that may underlie the symptoms of ME/CFS, 1743 potentially informing future diagnostic and therapeutic strategies. 1744 1745 <br><br> 1746 1747<br> Hatice Tankisi 1748Hatice Tankisi's research focuses on clinical neurophysiology, with a particular emphasis on peripheral nerve, muscle, and cortical 1749 excitability tests.<br> 1750 1751She investigates neurological disorders, particularly ALS and polyneuropathy, using electrophysiological markers to monitor disease 1752 progression and understand pathophysiology.<br> 1753 1754In the realm of ME research, Tankisi's work on neurophysiological biomarkers could potentially shed light on the neurological aspects 1755 of ME/CFS, although specific ME/CFS projects are not explicitly mentioned.<br> 1756 1757Her research is supported by various grants and institutional funding, and she is a member of several international research networks, 1758 including the European Multicenter EMG network and the International Diabetic Neuropathy Consortium.<br> 1759 1760Tankisi's contributions to neurophysiology provide valuable insights that could be relevant to understanding the neurological symptoms 1761experienced by ME/CFS patients. 1762 1763 <br> 1764 1765 1766 1767 1768 </div> 1769 </div> 1770 1771 1772 1773 1774 1775 <!-- Speaker Lightbox iceland -->
1776<div id="act-iceland" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 1777 <div class="row"> 1778 <div class="col-lg-2 col-sm-4 text-center"> 1779 <img src="../img/flags/act-iceland.jpg" class="img-fluid mb-2" width="190px"/> 1780 <p> Iceland 1781 1782 </div> 1783 <div class="col-lg-8 col-sm-8"> 1784 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in Iceland</h2> 1785 1786 <p> 1787Tekla H. Karlsdottir is involved in research related to the physical and cognitive impact following SARS-CoV-2 infection. 1788She has contributed to studies that compare symptoms reported after infection with medical evaluations, such as blood tests and sensory tests. 1789 1790 1791 <p> 1792Friðbjörn Sigurðsson is associated with the establishment of the Akureyri Clinic, a specialty clinic for patients with ME/CFS and long-Covid in Iceland. 1793The clinic aims to address the needs of patients and conduct research on ME/CFS. 1794 <p> 1795Sigurveig T. Sigurdardottir is the Head of the Department of Immunology at Landspitali University Hospital in Iceland. 1796Her research focuses on pediatrics, allergy, and clinical immunology, including studies on food allergy prevalence in Icelandic infants and the 1797characterisation of house dust mite sensitivity in a dust mite-free community 1798 <p> 1799 1800Kristján Erlendsson is an Associate Professor of Medical Education and Associate Dean of Education at the University of Iceland Medical Faculty. 1801His research interests include rheumatology, immunology, and complement studies. He has contributed to various publications in these fields. 1802 1803 1804 </div> 1805 </div> 1806</div> 1807 1808 1809 1810 1811 1812 <!-- Speaker Lightbox Sweden --> 1813<div id="act-sweden" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 1814 <div class="row"> 1815 <div class="col-lg-4 col-sm-4 text-center"> 1816 <img src="../img/flags/act-sweden.png" class="img-fluid mb-2" /> 1817 <p> Sweden 1818 </p> 1819 </div> 1820 <div class="col-lg-8 col-sm-8"> 1821 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2">
1821 Current ME Research in Sweden</h2> 1822 <p> 1823 Jonas Bergquist is a prominent researcher in the field of myalgic encephalomyelitis (ME) in Sweden. 1824 He is a Professor of Analytical Chemistry and Neurochemistry at Uppsala University. 1825 His research focuses on characterising the neuroimmunological aspects of ME using proteomics and metabolomics, 1826 with a particular interest in cerebrospinal fluid studies and autoantibodies. 1827 Bergquist's work aims to understand 1828 the origins of ME and develop potential treatments for this debilitating illness. 1829 1830 <p> 1831 Per Julin's recent research on ME included a study published in 2021 that investigated regional cerebral blood flow (rCBF) in ME/CFS patients. 1832 The study, titled "Limbic Perfusion Is Reduced in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)," used 1833 the pseudo-continuous arterial spin labeling (PCASL) technique on a whole-body clinical 3T MRI scanner. The findings revealed significant 1834 hypoperfusion in several brain regions of the limbic system in ME/CFS patients compared to healthy controls. 1835 This research highlights brain blood flow abnormalities that may contribute to ME/CFS pathogenesis 1836 1837 In 2023, he contributed to a study published in Oxford Open Immunology that focused on achieving symptom relief in ME patients by targeting 1838 the neuro-immune interface and optimizing disease tolerance. This research aimed to understand the pathogenesis of ME and develop strategies to alleviate symptoms by modulating the immune system's interaction with the nervous system. The study involved a cohort of ME patients and used advanced molecular techniques to identify potential therapeutic targets5 1839 1840 1841 1842 <p></p> 1843 Anders Rosén recently published a paper on 1844 Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and Autoantibodies to Type I Interferon in Sputum from 1845 ME Patients. 1846 1847 </div> 1848 </div> 1849</div> 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 <!-- Speaker Lightbox UK --> 1860<div id="act-uk" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 1861 <div class="row"> 1862 <div class="col-lg-4 col-sm-4 text-center"> 1863 <img src="../img/flags/act-uk.jpg" class="img-fluid mb-2" width="190px"/> 1864 <p> UK 1865 </p> 1866 </div> 1867 <div class="col-lg-8 col-sm-8"> 1868 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in UK</h2> 1869 <p> 1870 Simon Carding's recent research focuses on the role of the intestinal virome in myalgic encephalomyelitis (ME). He has been 1871 involved in studies investigating alterations in the intestinal virome and its potential contributions to ME, exploring how gut 1872 viruses may influence the development of the condition. His work emp
1872hasizes the importance of understanding the gut microbiota and virome 1873 in the context of ME, aiming to identify potential biomarkers and therapeutic targets 1874<p> 1875 1876Davis Price is known for his innovative research in the field of ME. He has been involved in developing cutting-edge technologies 1877and methodologies to better understand the pathophysiology of ME. His work includes the use of nanofabrication and advanced molecular 1878techniques to study the genetic and immunological aspects of the disease, aiming to identify biomarkers and potential therapeutic interventions 1879<p> 1880 1881Caroline Dalton's research focuses on the metabolic and immune dysfunctions associated with ME. 1882She has conducted studies that replicate findings related to micro-blood clots in ME patients, which restrict blood flow and contribute 1883to the symptoms of the condition. Her work involves using advanced imaging techniques to count the number of clots in blood, providing 1884insights into the mechanistic links between these clots and ME 1885 1886 1887 1888 </div> 1889 </div> 1890</div> 1891 1892 1893 1894 1895 1896 1897 1898 <!-- Speaker Lightboxnetherlands --> 1899<div id="act-netherlands" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 1900 <div class="row"> 1901 <div class="col-lg-4 col-sm-4 text-center"> 1902 <img src="../img/flags/act-netherlands.jpg" class="img-fluid mb-2" width="190px"/> 1903 <p> Netherlands 1904 </p> 1905 </div> 1906 <div class="col-lg-8 col-sm-8"> 1907 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in Netherlands</h2> 1908 1909 <p> 1910 ân May 2023, Dr. Jos Bosch, Associate Professor at the University of Amsterdam and researcher at Amsterdam UMC, 1911 commenced the Dutch ME/CFS Cohort- and Biobank (NMCB) Consortium. This eight-year project, funded with â¬7.2 million from ZonMw, 1912 aims to establish a national infrastructure for biomedical research into ME. 1913 The consortium focuses on understanding disease mechanisms, improving diagnostics, and exploring potential treatments. 1914 It involves collaboration among all Dutch university medical centres and includes home visits to severely affected patients 1915 to ensure comprehensive data collection. 1916 1917 1918 1919 1920 </div> 1921 </div> 1922</div> 1923 1924 1925 1926 1927 1928 1929 <!-- Speaker Lightbox -germany --> 1930<div id="act-germany" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 1931 <div class="row"> 1932 <div class="col-lg-4 col-sm-4 text-center"> 1933 <img src="../img/flags/act-germany.jpg" class="img-fluid mb-2" width="190px"/> 1934 <p> Germany 1935 </p> 1936 </div> 1937 <div class="col-lg-8 col-sm-8"> 1938 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in -Germany</h2> 1939 1940 1941 1942 1943 </div> 1944 </div> 1945</div> 1946 1947 1948 1949 1950 1951 1952 1953 <!-- Speaker Lightbox Spain --> 1954<div id="act-spain" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 1955 <div class="row"> 1956 <div class="col-lg-4 col-sm-4 text-center"> 1957 <img src="../img/flags/act-Spain.jpg" class="img-fluid mb-2" /> 1958 <p> Spain 1959 </p> 1960 </div> 1961 <div class="col-lg-8 col-sm-8"> 1962 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in Spain</h2> 1963 1964 Professor Elisa Oltra of the Universidad Católica de Valencia performs researc 1965 exploring the role of human endogenous retroviruses (HERVs) and their potential metabolic impact in patients with ME. 1966 1967 1968 </div> 1969 </div> 1970</div> 1971 1972 1973 1974 1975 1976 <!-- Speaker Lightbox Norway --> 1977<div id="act-norway" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 1978 <div class="row"> 1979 <div class="col-lg-4 col-sm-4 text-center"> 1980 <img src="../img/flags/norway.png" class="img-fluid mb-2" /> 1981 <p> Norway 1982 </p> 1983 </div> 1984 <div class="col-lg-8 col-sm-8"> 1985 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in Norway</h2> 1986 <p> 1987 Marte K. Viken: Leading the HLA and Disease project group at Oslo University Hospital, Viken's team focuses on immunogenetic studies related to ME. Their research includes identifying pathogenic cell phenotypes in ME patients and examining gene expression of HLA genes. 1988 1989 <p> 1990 Kristian Sommerfelt: Affiliated with the University of Bergen, Sommerfelt co-authored a study published in 1991 February 2023 titled "Severe and Very Severe Myalgic Encephalopathy/Chronic Fatigue Syndrome ME/CFS in Norway: Symptom Burden and Access to Care." 1992 This research highlighted the extensive symptom burden and inadequate healthcare support experienced by severely affected ME 1993 patients in Norwa. 1994 Building on this work, in June 2024, Professor Sommerfelt collaborated with colleagues to publish 1995 "Assessing Functional Capacity in Myalgic Encephalopathy/Chronic Fatigue Syndrome: A Patient-Informed Questionnaire." 1996 This study introduced the Functional Capacity (FUNCAP) questionnaire, developed with extensive patient feedback to accurately 1997 assess functional capacity in ME patients. 1998 1999 2000 2001 <p> 2002 2003 Ola Didrik Saugstad: A professor at the University of Oslo, 2004 played a pivotal role in establishing a specialised care service for severely ill ME 2005 patients at Røysumtunet, located near Oslo. 2006 Recognising the substantial need for institutional care among this patient group, 2007 Professor Saugstad was instrumental in identifying a suitable facility to accommodate them. 2008 He noted that many of these patients had been confined to their homes for extended periods, often relying solely 2009 on family members for care, and in some instances, had minimal contact with healthcare services. 2010 2011 2012 2013 </div> 2014 </div> 2015</div> 2016 2017 2018 2019 <!-- Speaker Lightbox Serbia -->
2020<div id="act-serbia" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 2021 <div class="row"> 2022 <div class="col-lg-4 col-sm-4 text-center"> 2023 <img src="../img/flags/act-serbia.jpg" class="img-fluid mb-2" /> 2024 <p> Serbia 2025 </p> 2026 </div> 2027 <div class="col-lg-8 col-sm-8"> 2028 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in Serbia</h2> 2029 2030 Professor Branislav MilovanoviÄ, Head of the Neurocardiological Laboratory at the Institute for Cardiovascular Diseases Dedinje in Belgrade, 2031 Serbia, organises the annual International Symposium on Neurocardiology (Neurocard 2023). 2032 2033 He also now organises an annual symposium for ME in Belgrade. 2034 2035 </div> 2036 </div> 2037</div> 2038 2039 2040 2041 2042 2043 2044 <!-- Speaker Lightbox Finland --> 2045<div id="act-finland" class="dialog dialog-lg zoom-anim-dialog mfp-hide p-5"> 2046 <div class="row"> 2047 <div class="col-lg-4 col-sm-4 text-center"> 2048 <img src="../img/flags/act-finland.jpg" class="img-fluid mb-2" width="190px"/> 2049 <p> Finland 2050 </p> 2051 </div> 2052 <div class="col-lg-8 col-sm-8"> 2053 <h2 class="text-color-dark font-weight-bold line-height-1 text-5 mt-0 mb-2"> Current ME Research in Finland</h2> 2054 2055 2056 Professor Markku Partinen of the University of Helsinki presented findings on dysautonomia, symptoms of ME, and Long COVID at the 2057 13th Biomedical Research into ME Colloquium (#BRMEC13). 2058 Additionally, he leads an ongoing project titled "Diagnostics and Categorization of Different Types of ME/CFS," which began in November 2059 2019. 2060 2061 He was also leading an ongoing research project titled "Diagnostics and Categorization of Different Types of ME/CFS," which commenced on 14 November 2062 2019. The project aims to enhance the diagnostic accuracy and classification of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) by identifying distinct subtypes of the condition. This initiative seeks to address the heterogeneity of ME/CFS presentations, which often complicates diagnosis and treatment. 2063 By delineating specific subcategories, the research aspires to facilitate more tailored therapeutic approaches and improve 2064 patient outcomes. 2065 </div> 2066 </div> 2067</div> 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 </div> 2080 </div> 2081 </div> 2082 </div> 2083 2084 2085 2086 <!-- 2087 2088 <div class="bg-grey-100 my-5 px-3 px-xl-0 border-radius-2 p-relative overflow-hidden"> 2089 <div class="container "> 2090 <div class="row "> 2091 <div class="col"> 2092 2093<!-- NEWS List ------------------------------------------------------------------------------------------------------------------ 2094<!-- include virtual="/00 Base-Common-Html/Base-Html-currentnews-list.html" 2095 2096 </div> 2097 </div> 2098 </div> 2099 </div> 2100 --> 2101 2102 2103 2104<!-- NEWS List --------------------------------------------------------------------------------------------------------------------> 2105 2106 <section class="section parallax border-0 pt-5 py-0 m-0" data-plugin-parallax="" 2107 data-plugin-options="{'spped': '1.5', 'parallaxHeight': '110%', 'fadeIn': true}" data-image-src="img/fp/newsitems.png" 2108 style="position: relative; overflow: hidden;"> 2109 <div class="parallax-background fadeIn animated" 2110 style="background-image: url("img/fp/newsitems.png"); 2111 background-size: cover; position: absolute; top: 0px; left: 0px; width: 100%; height: 112%; transform: translate3d(0px, -58.4105px, 0px); 2112 background-position-x: 50%;"> 2113 2114 </div> 2115 <div class="container"> 2116 <div class="row gy-5"> 2117 <div class="col-lg-4 text-center order-2 order-lg-1"> 2118 2119 </div> 2120 <div class="col-lg-8 align-self-center pb-lg-5 order-1 order-lg-2 ps-5 ps-lg-0"> 2121 2122 <h2 class="text-color-secondary font-weight-bold text-capitalize mb-4 custom-letter-spacing-2 custom-text-1"> 2123 Current News Items 2124 </h2> 2125<!----------------------------------------------------------------------------------------------------------------------------------------------------> 2126<!-- EVENTS block --> 2127 <p class="lead"> 2128 2129 A summary of recent and current news. 2130 <br> 2131 These include news items concerning EMERG researchers and clinicians, also Young EMERG and early career 2132 topics and relevant news from the European ME Alliance. 2133 <br> 2134 The expertise of EMERG members means that the group can be a powerful influence when research expertise 2135 is required at conferences and educational events. 2136 2137 2138 </p> 2139<!-- Upcoming Events ------------------------------------------------------------------------------------> 2140 <div class="col"> 2141 2142 2143 <!-- <div class="accordion accordion-modern-status accordion-modern-status-primary" id="accordioncurr"> --> 2144 <div class="accordion" id="accordioncurr"> 2145<!-- Upcoming Events ------------------------------------------------------------------------------------> 2146<!-- 2023 News Items -----------------------------------------------------------------------------------------------------------------------> 2147 2148<!--EU Horizon award---> 2149 2150 <div class="card card-default"> 2151 <div class="card-header"> 2152 <h4 class="card-title m-0 text-4"> 2153 <a class="accordion-toggle collapsed" data-bs-toggle="collapse" data-bs-parent="#accordion26" href="#collapse262"> 2154 <i class="fas fa-bars"></i> 2155 June 2026: EMECC restarts clinicians' meetings following #BRMEC15 Colloquium 2156 </a> 2157 </h4> 2158 </div> 2159 <div id="collapse262" class="collapse" style=""> 2160 <div class="card-body"> 2161 <p class="lead"> 2162 EMECC has restarted its clinicians' meetings following the #BRMEC15 Colloquium in Cambridge, UK, in May and now has 2163 international partners collaborating. 2164 2165 </p> 2166 <p style="text-align: right"> 2167 <a href="../emergnews260801-emecc.shtml" class="btn btn-secondary btn-outline text-color-dark font-weight-semibold border-width-4 custom-link-effect-1 text-1 text-xl-3 d-inline-flex align-items-center px-4 py-3">Read more <i class="custom-arrow-icon ms-2"></i></a> 2168 </p> 2169 </div> 2170 </div> 2171 </div> 2172 2173 2174 2175 <div class="card card-default"> 2176 <div class="card-header"> 2177 <h4 class="card-title m-0 text-4"> 2178 <a class="accordion-toggle collapsed" data-bs-toggle="collapse" data-bs-parent="#accordion26" href="#collapse261"> 2179 <i class="fas fa-bars"></i> 2180 June 2026: EMERG-led consortium wins EU Horizon award 2181 </a> 2182 </h4> 2183 </div> 2184 <div id="collapse261" class="collapse" style=""> 2185 <div class="card-body"> 2186 <p class="lead"> 2187 An EMERG-led consortium has been awarded the from the first EU research call ever to name ME explicitly as a priority condition 2188 2189 </p> 2190 <p style="text-align: right"> 2191 <a href="../emergnews260601.shtml" class="btn btn-secondary btn-outline text-color-dark font-weight-semibold border-width-4 custom-link-effect-1 text-1 text-xl-3 d-inline-flex align-items-center px-4 py-3">Read more <i class="custom-arrow-icon ms-2"></i></a> 2192 </p> 2193 </div> 2194 </div> 2195 </div> 2196 2197 </div> 2198 </div> 2199 2200 <a href="news.shtml"> 2201 <button type="button" class="btn btn-outline btn-primary text-uppercase mt-4 mb-4 mb-md-0 font-weight-bold"> 2202 Read all news items</button></a> 2203 2204 </div> 2205 </div> 2206 </div> 2207 </section> 2208 2209 2210 2211 2212 2213 2214 <div class="bg-grey-100 my-5 px-3 px-xl-0 border-radius-2 p-relative overflow-hidden"> 2215 <div class="container "> 2216 <div class="row "> 2217 <div class="col"> 2218 2219<!-- Events List --------------------------------------------------------------------------------------------------------------------> 2220 2221 <section class="section bg-transparent m-0 border-0"> 2222 <div class="container"> 2223 <div class="row py-2"> 2224 <div class="col-lg-3 text-lg-left"> 2225 2226 2227 <img class="img-fluid " 2228 src="img/events/IMG_0370-2023.png" data-plugin-options="{'accY': -400}" alt="" > 2229 2230 2231 </div> 2232 2233 2234 <div class="col-lg-9 col-md-4"> 2235 2236 <h2 class=" font-weight-bold text-6">Recent/Upcoming Events</h2> 2237<!----------------------------------------------------------------------------------------------------------------------------------------------------> 2238<!-- EVENTS block --> 2239 2240 <p class="lead"> 2241 2242 Upcoming and recent events involving EMERG, Young EMERG and EMEA. 2243 <br> 2244 2245 These included workshops and conferences. 2246 <br> 2247 The expertise of EMERG members means that the group can be a powerful influence when research expertise 2248 is required at conferences and educational events. 2249 2250 2251 </p> 2252<!-- Upcoming Events ------------------------------------------------------------------------------------> 2253 2254 2255 <div class="accordion" id="accordion"> 2256 2257 2258 2259 2260 <div class="card card-default"> 2261 <div class="card-header"> 2262 <h4 class="card-title m-0"> 2263 <a class="accordion-toggle" data-bs-toggle="collapse" data-bs-parent="#accordion" href="#collapse239"> 2264 <i class="fa fa-globe"></i> 2265 28-29 November 2025- Young EMERG International ME Workshop, Austria 2266 </a> 2267 </h4> 2268 </div> 2269 <div id="collapse239" class="collapse"> 2270 <div class="card-body"> 2271 The European ME Research Group (Young EMERG) - a network of 2272 young or early career researchers for ME - will hold an international ME workshop for 2273 early career researchers in Vienna, Austria. 2274 A meeting will be held on 28-29 November 2025 at the Medical University of Vienna. 2275 2276 <a href="https://youngemerg.com/yemerg06v.shtml" target="_blank">Read more</a> 2277 </div> 2278 </div> 2279 </div> 2280 2281 <div class="card card-default"> 2282 <div class="card-header"> 2283 <h4 class="card-title m-0"> 2284 <a class="accordion-toggle" data-bs-toggle="collapse" data-bs-parent="#accordion" href="#collapse239"> 2285 <i class="fa fa-globe"></i> 2286 25-26 May 2026- You
2286ng EMERG International ME Workshop, UK 2287 </a> 2288 </h4> 2289 </div> 2290 <div id="collapse239" class="collapse"> 2291 <div class="card-body"> 2292 The European ME Research Group (Young EMERG) - a network of 2293 young or early career researchers for ME - will hold its annual international workshop 2294 A meeting will be held on 26-27 May in Cambridge, UK, with international delegates. 2295 <a href="https://youngemerg.com/yemerg07.shtml" target="_blank">Read more</a> 2296 </div> 2297 </div> 2298 </div> 2299 2300 2301 <div class="card card-default"> 2302 <div class="card-header"> 2303 <h4 class="card-title m-0"> 2304 <a class="accordion-toggle" data-bs-toggle="collapse" data-bs-parent="#accordion" href="#collapse240"> 2305 <i class="fa fa-globe"></i> 2306 27 May 2026- EMERG Annual Meeting + collaborative workshop, UK 2307 </a> 2308 </h4> 2309 </div> 2310 <div id="collapse240" class="collapse"> 2311 <div class="card-body"> 2312 European ME Research Group meeting in Cambridge, UK, 2313 2314 <a href="https://www.investinme.org/emerg26.shtml" target="_blank">Read more</a> 2315 </div> 2316 </div> 2317 </div> 2318 2319 2320 <div class="card card-default"> 2321 <div class="card-header"> 2322 <h4 class="card-title m-0"> 2323 <a class="accordion-toggle" data-bs-toggle="collapse" data-bs-parent="#accordion" href="#collapse237"> 2324 <i class="fa fa-globe"></i> 2325 27-29 May 2026- 15th International Biomedical Research into ME Colloquium, UK 2326 </a> 2327 </h4> 2328 </div> 2329 <div id="collapse237" class="collapse"> 2330 <div class="card-body"> 2331 #BRMEC15 - the fifteenth International Biomedical Research into ME Colloquium - held in UK by UK charity 2332 Invest in ME Research - on 27th - 29th May 2026 - with chairing and input from EMERG 2333 <a href="https://www.investinme.org/BRMEC15.shtml " target="_blank">More details here</a>. 2334 </div> 2335 </div> 2336 </div> 2337 2338 2339 2340 2341 </div> 2342 2343 2344 2345 <a href="events.shtml"><button type="button" class="btn btn-outline btn-primary text-uppercase mt-4 mb-4 mb-md-0 font-weight-bold">read more</button></a> 2346 2347 2348 2349 </div> 2350 2351 2352 </div> 2353 </div> 2354 </section> 2355 2356 <!-- include virtual="/00 Base-Common-Html/Base-Html-currentnews-emergevents.html" --> 2357 2358 </div> 2359 </div> 2360 </div> 2361 </div> 2362 2363 2364 2365 2366 2367 2368 <section class="section parallax border-0 pt-5 py-0 m-0" data-plugin-parallax="" 2369data-plugin-options="{'spped': '1.5', 'parallaxHeight': '125%', 'fadeIn': true}" data-image-src="img/fp/commentsworld.jpg" 2370style="position: relative; overflow: hidden;"> 2371 <div class="parallax-background fadeIn animated" 2372 style="background-image: url("img/fp/commentsworld.jpg"); 2373 background-size: cover; position: absolute; top: 0px; left: 0px; width: 100%; height: 125%; transform: translate3d(0px, -58.4105px, 0px); 2374 background-position-x: 50%;"> 2375 2376 </div> 2377 <div class="container"> 2378 <div class="row gy-5"> 2379 <div class="col-lg-3 text-center order-2 order-lg-1"> 2380 2381 </div> 2382 <div class="col-lg-9 align-self-center pb-lg-5 order-1 order-lg-2 ps-5 ps-lg-0"> 2383 <div class="testimonial testimonial-style-2 testimonial-with-quotes testimonial-remove-right-quote 2384 testimonial-quotes-dark custom-testimonial-quote-position-1 mb-0"> 2385<!----------------------------------------------------------------------------------------------------------------------------------------------------> 2386 <div class="container"> 2387 2388 <h4 class=" text-lg-8 font-weight-semibold line-height-1 "> 2389 2390 Comments on EMERG 2391 </h4> 2392 <div class="col appear-animation animated fadeInUpShorter appear-animation-visible" 2393 data-appear-animation="fadeInUpShorter" data-appear-animation-delay="200" style="animation-delay: 200ms;"> 2394 2395 <div class="owl-carousel owl-theme stage-margin stage-margin-lg nav
2395-dark nav-style-2 mb-0 owl-loaded owl-drag owl-carousel-init" data-plugin-options="{'items': 1, 'margin': 100, 'loop': false, 'nav': true, 'dots': false, 'stagePadding': 100, 'autoHeight': true}" style="height: auto;"> 2396 2397 2398 <div class="owl-stage-outer owl-height" style="height: 242.617px;"> 2399 <div class="owl-stage" style="transform: translate3d(-1016px, 0px, 0px); transition: 0.25s; width: 2232px; padding-left: 100px; padding-right: 100px;"> 2400 2401 2402 <div class="owl-item active" style="width: 910px; margin-right: 100px;"> 2403 <div> 2404 <div class="testimonial testimonial-style-4 mb-0"> 2405 <blockquote class="with-bordersIIMER"> 2406 <p class="mb-0"> 2407 This is very exciting! 2408 <br>I believe this move will jump Europe well to the lead 2409 <br>in tackling the unanswered questions about ME. 2410 2411 </blockquote> 2412 <div class="testimonial-author"> 2413 <p><strong class="font-weight-extra-bold">B</strong> USA </p> 2414 2415 </div> 2416 </div> 2417 </div> 2418 </div> 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 <div class="owl-item" style="width: 910px; margin-right: 100px;"> 2430 <div> 2431 <div class="testimonial testimonial-style-4 mb-0"> 2432 <blockquote class="with-bordersIIMER"> 2433 <p class="mb-0"> 2434 2435 The establishment of EMERG is very good news. 2436 <br> 2437 <br> 2438 2439 </blockquote> 2440 <div class="testimonial-author"> 2441 <p><strong class="font-weight-extra-bold">E</strong>Norway</p> 2442 </div> 2443 </div> 2444 </div> 2445 </div> 2446 2447 2448 2449 <div class="owl-item" style="width: 910px; margin-right: 100px;"> 2450 <div> 2451 <div class="testimonial testimonial-style-4 mb-0"> 2452 <blockquote class="with-bordersIIMER"> 2453 <p class="mb-0"> 2454 We and our members are glad to hear of this research 2455 <br>development and the desire 2456 <br>âto work more cooperatively and effectivelyâ. 2457 </blockquote> 2458 <div class="testimonial-author"> 2459 <p><strong class="font-weight-extra-bold">D</strong> Australia</p> 2460 </div> 2461 </div> 2462 </div> 2463 </div> 2464 2465 2466 2467 <div class="owl-item" style="width: 910px; margin-right: 100px;"> 2468 <div> 2469 <div class="testimonial testimonial-style-4 mb-0"> 2470 <blockquote class="with-bordersIIMER"> 2471 <p class="mb-0"> 2472 Congratulations on the good work - 2473 <br>a step forward for all ME sufferers 2474 <br> 2475 </blockquote> 2476 <div class="testimonial-author"> 2477 <p><strong class="font-weight-extra-bold">C</strong>Europe</p> 2478 </div> 2479 </div> 2480 </div> 2481 </div> 2482 2483 2484 2485 2486 <div class="owl-item" style="width: 910px; margin-right: 100px;"> 2487 <div> 2488 <div class="testimonial testimonial-style-4 mb-0"> 2489 <blockquote class="with-bordersIIMER"> 2490 <p class="mb-0"> 2491 Congratulations and very best wishes for 2492 <br>European collaboration in ME 2493 <br> 2494 2495 </blockquote> 2496 <div class="testimonial-author"> 2497 <p><strong class="font-weight-extra-bold">J</strong>UK</p> 2498 </div> 2499 </div> 2500 </div> 2501 </div> 2502 2503 2504 2505 2506 <div class="owl-item" style="width: 910px; margin-right: 100px;"> 2507 <div> 2508 <div class="testimonial testimonial-style-4 mb-0"> 2509 <blockquote class="with-bordersIIMER"> 2510 <p class="mb-0"> 2511 exciting developments with EMERG. 2512 <br>This collaboration promises to bring together many of the 2513 <br>
2513best researchers in Europe and to consolidate research findings 2514 <br>and funding opportunities. 2515 <br>Certainly the critical mass this will bring to ME research in Europe 2516 <br>will be formidable. Congratulations 2517 2518 </blockquote> 2519 <div class="testimonial-author"> 2520 <p><strong class="font-weight-extra-bold">D</strong>Australia</p> 2521 </div> 2522 </div> 2523 </div> 2524 </div> 2525 2526 2527 2528 2529 <div class="owl-item" style="width: 910px; margin-right: 100px;"> 2530 <div> 2531 <div class="testimonial testimonial-style-4 mb-0"> 2532 <blockquote class="with-bordersIIMER"> 2533 <p class="mb-0"> 2534 The formation of EMERG is indeed great news 2535 <br> 2536 <br> 2537 2538 </blockquote> 2539 <div class="testimonial-author"> 2540 <p><strong class="font-weight-extra-bold">A</strong>Eire</p> 2541 </div> 2542 </div> 2543 </div> 2544 </div> 2545 2546 2547 2548 2549 2550 2551 2552 </div> 2553 </div> 2554 <div class="owl-nav"> 2555 <button type="button" role="presentation" class="owl-prev"> 2556 2557 </button> 2558 <button type="button" role="presentation" class="owl-next disabled"> 2559 2560 </button> 2561 </div> 2562 <div class="owl-dots disabled"> 2563 2564 </div> 2565 </div> 2566 2567 </div> 2568 </div> 2569 2570 </div> 2571 </div> 2572 </div> 2573 </div> 2574 </section> 2575 <a id="contact"></a> 2576 2577 <div class="bg-grey-100 my-5 px-3 px-xl-0 border-radius-2 p-relative overflow-hidden"> 2578 <div class="container "> 2579 <div class="row "> 2580 <div class="col"> 2581 2582 2583<section> 2584 <div class="container mb-3"> 2585 <div class="row"> 2586 <div class="col-md-4 order-2 order-md-1 p-static"> 2587 <img class="img-fluid" src="img/fp/229298249_11007142.png" 2588 alt="contact us"> 2589 </div> 2590 <div class="col-md-8 order-1 order-md-2 "> 2591 2592<div class="container"> 2593 <div class="row pb-2 mb-4"> 2594 <div class="col "> 2595 <h2 class="text-color-dark font-weight-bold text-10 mb-2">Contact</h2> 2596 <p class="text-color-dark opacity-6 text-4">Please use the form below to contact us<br> 2597 Alternatively email to <a href="mailto:[email protected]" target="_blank"> 2598 <img src="img/emergemailaddr.png" width="300" height="60" alt="email Emerg"> 2599 </a> 2600 </p> 2601 2602 2603 2604 <div class="row "> 2605 <div class="col-lg-12"> 2606 2607 2608 <form id="contactForm" class="contact-form" action="php/em-contact-form-recaptcha25i.php" method="POST"> 2609 2610 <div class="form-row"> 2611 <div class="form-group col"> 2612 <label>Your name *</label> 2613 <input type="text" value="" data-msg-required="Please enter your name." maxlength="100" class="form-control" name="name" id="name" required> 2614 </div> 2615 </div> 2616 2617 <div class="form-row"> 2618 <div class="form-group col"> 2619 <label>Your e-mail address *</label> 2620 <input type="text" value="" data-msg-required="Please enter your email address." maxlength="100" class="form-control" name="email" id="email" required> 2621 </div> 2622 </div> 2623 2624 2625 2626 <div class="form-row"> 2627 <div class="form-group col"> 2628 <label>Subject *</label> 2629 <input type="text" value="" data-msg-required="Please enter the subject." maxlength="100" class="form-control" name="subject" id="subject" required> 2630 </div> 2631 </div> 2632 <div class="form-row"> 2633 <div class="form-group col"> 2634 <label>Message *</label> 2635 <textarea maxlength="5000" data-msg-required="Please enter your message." rows="10" class="form-control" name="message" id="message" required></textarea> 2636 </div> 2637 </div> 2638 <div class="form-row"> 2639 <div class="form-group col"> 2640 <input type="submit" value="Send Message" class="btn btn-primary btn-lg" data-loading-text="Loading..."> 2641 </div> 2642 </div> 2643 </form> 2644 2645 2646<!-- Include reCAPTCHA API -->
vendor: 119 bytes, lines 2646-2654
2646 2647<script src="https://www.google.com/recaptcha/api.js" async defer></script> 2648 2649 2650 2651 2652 2653 2654
2654</div> 2655 </div> 2656 </div> 2657 </div> 2658 </div> 2659 2660 2661 </div> 2662 </div> 2663 </div> 2664 </section> 2665 2666 </div> 2667 </div> 2668 </div> 2669 </div> 2670 2671 2672 2673 2674 2675 2676 2677 2678 </div> 2679 2680 <!-- include virtual="/00 Base-Common-Html/Base-Html-EMERG-footer25-V01.html" --> 2681 2682<footer id="footer" class="bg-color-primary border-0 mt-0"> 2683 <div class="container"> 2684 2685 <div class="row my-4"> 2686 <div class="col-md-8 col-lg-8 mb-4 mb-lg-0"> 2687 <H4 class="mb-3">EMERG</H4> 2688 <p class="pr-1"><span style="color: #FFFFFF">The European ME Research Group (EMERG) is a network of 2689 European ME researchers performing 2690 biomedical research into myalgic encephalomyeltis (ME)</span></p> 2691 2692 </div> 2693 <div class="col-md-6 col-lg-2 mb-4 mb-lg-0"> 2694 2695 2696 <H4 class="text-4 mb-2">CONTACT US</H4> 2697 <ul class="list list-icons list-icons-lg"> 2698 2699 <li class="mb-1"><i class="far fa-envelope text-color-tertiary"></i><p class="m-0"><a href="em-contact.shtml">Contact EMERG</a></p></li> 2700 </ul> 2701 2702 2703 2704 </div> 2705 <div class="col-md-6 col-lg-2"> 2706 <H4 class="text-4 mb-3">FOLLOW US</H4> 2707 <ul class="header-social-icons social-icons"> 2708 <li class="social-icons-twitter"><a href="https://twitter.com/euromeresearch" target="_blank" title="Twitter"><i class="fab fa-twitter"></i></a></li> 2709 <!-- <li class="social-icons-linkedin"><a href="http://www.linkedin.com/" target="_blank" title="Linkedin"><i class="fab fa-linkedin-in"></i></a></li> 2710 --> 2711 </ul> 2712 2713 2714 2715 </div> 2716 </div> 2717 </div> 2718 2719 <div class="footer-copyright bg-color-primary"> 2720 <div class="container py-2"> 2721 <hr class="my-0 bg-color-light opacity-2"> 2722 <div class="row py-4"> 2723 <div class="col-lg-2 d-flex align-items-center justify-content-center justify-content-lg-start mb-2 mb-lg-0"> 2724 <a href="em-index.shtml" class="logo pr-0 pr-lg-3"> 2725 <img alt="EMERG" src="img/logos/logoem.png" class="opacity-5" height="33"> 2726 </a> 2727 </div> 2728 <div class="col-lg-6 d-flex align-items-center justify-content-center justify-content-lg-start mb-4 mb-lg-0"> 2729 <p><span style="color: #FFFFFF">European ME Research Group © Copyright 2020. All Rights Reserved.</span></p> 2730 </div> 2731 <div class="col-lg-4 d-flex align-items-center justify-content-center justify-content-lg-end"> 2732 <nav id="sub-menu"> 2733 <ul> 2734 <li><i class="fas fa-angle-right"></i><a href="faqs.shtml" class="ml-1 text-decoration-none"> 2735 <span style="color: #FFFFFF">FAQ's</span></a></li> 2736 <li><i class="fas fa-angle-right"></i><a href="sitemap.shtml" class="ml-1 text-decoration-none"> <span style="color: #FFFFFF">Sitemap</span></a></li> 2737 <li><i class="fas fa-angle-right"></i><a href="Disclaimer.shtml" class="ml-1 text-decoration-none"> 2738 <span style="color: #0099FF">Disclaimer</span></a></li> 2739 </ul> 2740 </nav> 2741 </div> 2742 </div> 2743 </div> 2744 </div> 2745 2746 2747 2748 </footer> 2749 2750
2751<!-- for cookies -->
2752<script src="https://cdn.jsdelivr.net/npm/cookieconsent@3/build/cookieconsent.min.js" data-cfasync="false"></script>
2752
2753<script> 2754window.cookieconsent.initialise({ 2755 "palette": { 2756 "popup": { 2757 "background": "#252e39" 2758 }, 2759 "button": { 2760 "background": "#14a7d0" 2761 } 2762 }, 2763 "theme": "edgeless", 2764 "content": { 2765 "message": "We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.", 2766 "dismiss": "OK" 2767 } 2768}); 2769</script>
2769 2770 2771 2772 </div> 2773 2774 <!-- Vendor --> 2775
2775<script src="vendor/plugins/js/plugins.min.js"></script>
2775 2776 2777 <!-- Theme Base, Components and Settings --> 2778
2778<script src="js/theme.js"></script>
2778 2779 2780 <!-- Demo --> 2781
2781<script src="js/demos/demo-it-services.js"></script>
2781 2782 2783 <!-- Theme Custom --> 2784
2784<script src="js/custom.js"></script>
2784 2785 2786 <!-- Theme Initialization Files --> 2787
2787<script src="js/theme.init.js"></script>
2787 2788 2789 2790
2790<script>src="vendor/jquery.validation/jquery.validate.min.js"></script>
2790 2791 2792 <!-- Current Page Vendor and Views ***************recaptcha *****************--> 2793
2793<script src="js/views/view.contact.js"></script>
vendor: 129 bytes, lines 2793-2799
2793 2794 <script id="google-recaptcha" src="https://www.google.com/recaptcha/api.js" async defer></script> 2795 2796 2797 2798 2799
2799<!-- Google Analytics: Change UA-XXXXX-X to be your site's ID. Go to http://www.google.com/analytics/ for more information. 2800
2800<script>
vendor: 395 bytes, lines 2800-2806
2800 2801 (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ 2802 (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), 2803 m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m) 2804 })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); 2805 2806 ga('create', '
2806UA-12345678-1
vendor: 58 bytes, lines 2806-2808
2806', 'auto'); 2807 ga('send', 'pageview'); 2808
2808</script>
2808 2809 --> 2810 2811 2812 2813 2814 2815 </body> 2816</html>
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.